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Amacrine cells are a class of retinal interneurons that process the visual signal in 
the inner retina. Several subtypes of amacrine cells express nitric oxide synthase and 
produce nitric oxide (NO), making NO a possible regulator of amacrine cell function.  My 
dissertation research tests the hypothesis that NO alters amacrine cell GABAergic 
synaptic output.  To investigate this, I made whole-cell voltage clamp recordings of 
cultured chick amacrine cells receiving synaptic input from other amacrine cells and 
Ca2+ imaging of amacrine cell dendrites, which can be presynaptic.  I find that NO-
dependent increases in GABAergic spontaneous postsynaptic current (sPSC) frequency 
are independent of soluble guanylate cyclase and action potentials. Removal of 
extracellular Ca2+ and buffering of cytosolic Ca2+ both inhibit the response to NO. In 
Ca2+ imaging experiments, I confirm that NO increases dendritic Ca2+ by activating a 
Ca2+ influx pathway. Neither NO-dependent dendritic Ca2+ elevation nor increase in 
sPSC frequency are dependent upon Ca2+ release from stores. NO also enhances 
evoked GABAergic responses, and because voltage-gated Ca2+ channel function is not 
altered by NO, the enhanced evoked release is likely due to the combination of voltage-
dependent Ca2+ influx and the voltage-independent, NO-dependent Ca2+ influx. Insight 
into the identity of the Ca2+ channel involved in the NO response was provided by 
characteristics unique to the transient receptor potential canonical (TRPC) channel 
subunits 4 and 5: the NO-dependent increase in sPSC frequency was dependent on 
downstream activity of PLC, blocked by 2 mM La3+ and enhanced by 10 µM La3+. The 
TRPC inhibitor ML204, which preferentially blocks TRPC4, had no effect on the NO 
response at 10 µM, but 20 µM ML204 blocked the NO response. The TRPC inhibitor 
 xii 
clemizole, which preferentially blocks TRPC5, blocked NO-dependent dendritic Ca2+ 
elevations and the increase in sPSC frequency. Genetic knockdown of TRPC5 in 
cultured amacrine cells using the CRISPR/Cas9 system confirms that TRPC5 mediates 
NO-dependent dendritic Ca2+ elevations and the increase in sPSC frequency. These 
results suggest that NO-dependent activation of TRPC5 at amacrine cell presynaptic 





The vertebrate retina is the photosensory organ responsible for the detection of 
light in vision (See Figure 1.1). On the input side of the retina, also called the outer 
nuclear layer (ONL), visual signals from the environment are initiated by the patterns of 
photons (for example, the different photon patterns of the text you are reading here) 
interacting with photoreceptors, which are the cells responsible for converting the arrival 
of photons into neural signals. On the output side of the retina, ganglion cells in the 
ganglion cell layer (GCL) project their axons to the brain via the optic nerve. Ultimately, 
the visual signals are sent to the visual cortex in the brain for further processing and 
interpretation. Before being sent to the brain, the visual signal is processed within the 
retina itself.  There are 3 classes of interneurons (bipolar cells, horizontal cells and 
amacrine cells) between the photoreceptors and ganglion cells that communicate with 
each other to process the visual signal.  The cell bodies of all interneurons lie in the 
inner nuclear layer (INL). Bipolar cells complete the vertical pathway of the visual signal 
between photoreceptor and ganglion cells by receiving synaptic input from 
photoreceptors in the outer plexiform layer (OPL) and sending synaptic output to 
ganglion cells in the inner plexiform layer (IPL). Horizontal cells interact with 
photoreceptors, bipolar cells and other horizontal cells in the OPL to adjust the receptive 
fields of bipolar cells. Amacrine cells (ACs) have synaptic interactions in the IPL with 
bipolar cells, ganglion cells, and other ACs.  The most common synaptic partner of ACs, 























Figure 1.1. Schematic of cellular and synaptic organization in the vertebrate retina. Light 
enters the eye and transverses through all layers of the retina. Cell bodies of rod 
photoreceptors (R) and cone photoreceptors (C) lie in the outer nuclear layer (ONL) and 
convert the arrival of photons into a neural signal. The cell bodies of bipolar cells (B), 
horizontal cells (H) and amacrine cells (A) lie in the inner nuclear layer (INL). Cell 
bodies of ganglion cells and displaced amacrine cells lie in the ganglion cell layer 
(GCL). Synaptic interactions between photoreceptors, bipolar cells and horizontal cells 
occur in the outer plexiform layer outer plexiform layer (OPL). Synaptic interactions 
between bipolar cells, amacrine cells and ganglion cells occur in the inner plexiform 
later (IPL). Ganglion cell axons form the optic nerve that projects to the brain.  
 
Retinal amacrine cells 
Retinal ACs are the cells of interest in our lab because they form majority of 
synapses in the IPL (Marc and Liu 2000). Therefore, ACs must have an important role 
in shaping retinal signals. There are ~40 morphologically different types of ACs in the 
vertebrate retina. Different AC morphologies suggest different functions, and 
understanding their contribution is essential to understanding how visual information is 
conveyed and shaped in the inner retina. AC somas are located within the INL, as well 
as some that are displaced to the GCL, and send their processes into the IPL where 
 3 
they form reciprocal, serial, and/or lateral synapses with bipolar cells, ganglion cells, 
and other ACs. Even though the functions of majority of ACs remain unknown, the 
functions of some subtypes have been identified. 
Dopaminergic ACs are wide-field (extend their dendrites laterally > 500 µm) and 
synthesize dopamine, a neurotransmitter which works in a paracrine manner in the 
retina. Under scotopic (low) light, horizontal cells are electrically coupled via gap 
junctions, which increases sensitivity to light but decreases visual resolution. As 
photopic (bright) light range is reached, dopaminergic ACs release dopamine, which in 
turn acts on the dopamine receptor 1 (DR1) on horizontal cells (Nguyen-Legros et al. 
1999). The DR1 is a G-protein coupled receptor that activates adenylyl cyclase, which 
subsequently activates a cAMP-sensitive protein kinase (Lasater 1987). This pathway 
leads to horizontal cell uncoupling, which enhances visual resolution by reducing the 
receptive field of bipolar cells (Shen et al. 2003). The light-dependent release of 
dopamine also leads to AII AC uncoupling (see below). 
AII (A2) ACs (Vaney et al. 1991) are narrow-field (extend their dendrites 
vertically), glycinergic cells that serve to integrate signals arising from the rod 
photoreceptor pathway into the cone photoreceptor pathway (Demb and Singer 2012). 
The rod pathway is thought to have evolved after the cone pathway because rod bipolar 
cells “piggyback” onto the cone pathway by synapsing onto AII ACs, which in turn 
synapse onto OFF-cone bipolar cells and form gap junctions with ON-cone bipolar cells 
(Demb and Singer 2012; Strettoi et al. 1992). AII ACs also form gap junctions with other 
AII ACs.  This electrical coupling functions to amplify the rod pathway by increasing the 
receptive field beyond the dendritic field of AII ACs (Mills and Massey 1995). 
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Starburst amacrine cells (SBACs) are direction-selective, wide-field ACs. SBACs 
are both GABAergic and cholinergic and function in direction selectivity by differentially 
inhibiting direction-selective ganglion cells (Taylor and Smith 2012). SBACs are the only 
retinal cell type known to release acetylcholine.  
These three types of ACs play an important role in shaping the visual signal that 
ganglion cells send to visual regions of the brain. The functions just among these three 
types of ACs are very diverse, suggesting that the theme of diverse functions for ACs is 
likely to persist as we learn more.  
Retinal amacrine cell signaling 
Neurons are generally considered to be highly polarized cells that receive 
synaptic input from other neurons at their dendrites, transform the synaptic input into 
action potentials that propagate down their axon, and then generate synaptic output 
from the axonal synaptic terminal (e.g. motor neurons). Many types of ACs, however, do 
not have formal axons. Instead, ACs form complex microcircuits within dual function 
dendrites: synaptic input is received and synaptic output can be generated within the 
same dendrite (Chavez et al. 2010; Grimes et al. 2010; Grimes et al. 2015; Tsukamoto 
et al. 2001). AC microcircuits formed by these mixed-use dendrites allow for highly-
localized synaptic signaling in dendrites, which can also have localized Ca2+ elevations 
(Euler et al. 2002). AC dendritic Ca2+ elevations are initiated by presynaptic bipolar cell 
glutamate release. Activation of AC glutamate receptors alone is sufficient to trigger 
GABA release at localized reciprocal synapses (Chavez and Diamond 2008; Chavez et 
al. 2006; Grimes et al. 2015). At more lateral AC synapses, action potentials are 
involved in GABA release (Chavez et al. 2010; Cook and McReynolds 1998; Cook and 
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Werblin 1994; Shields and Lukasiewicz 2003). Voltage-gated L-type Ca2+ channels are 
localized at narrow-field AII AC output synapses (Habermann et al. 2003) and mediate 
neurotransmitter release in wide-field GABAergic ACs (Vigh and Lasater 2004).  
AC intracellular Ca2+ stores can also play a role in synaptic signaling by 
enhancing evoked and spontaneous release of GABA through Ca2+-induced Ca2+ 
release (CICR) via IP3 receptors (IP3Rs) (Warrier et al. 2005) and/or ryanodine 
receptors (RyRs) (Chavez et al. 2006). One study, recording from cultured ACs that 
express both IP3Rs and RyRs, demonstrated that CICR through IP3Rs, not RyRs, 
enhances GABA release (Warrier et al. 2005). However, another study recording from 
A17 ACs in rat retinal slices demonstrated that CICR through RyRs, not IP3Rs, 
enhanced depolarization-independent, but glutamate-dependent GABA release 
(Chavez et al. 2006).  It is unclear, however, if IP3R- and RyR-pathways are involved in 
Ca2+ signaling in the same AC or if each pathway is specific to certain AC subtypes 
(Chavez et al. 2006; Warrier et al. 2005). Any modulation in localized AC Ca2+ signaling 
at presynaptic sites will alter their synaptic output, which is important for proper 
processing of the visual signal.  
Nitric oxide in the retina 
Nitric oxide (NO) is a gaseous messenger molecule synthesized by the enzyme 
nitric oxide synthase (NOS). The substrate for NOS is L-arginine, and the products are 
L-citrulline and NO (Figure 1.2). Two calcium/calmodulin (Ca2+/CaM)-dependent 
isoforms of NOS, neuronal NOS (nNOS) and endothelial NOS (eNOS), and one 
calcium-independent isoform, inducible NOS (iNOS), have all been shown to be 
expressed with variable degree in the vertebrae retina (Donovan et al. 2001; Knowles 
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and Moncada 1994; Miyagi et al. 2002; Piehl et al. 2007). The isoform nNOS is 
constitutively expressed in subsets of all cell types in the vertebrate retina, and recently, 
the isoform eNOS has been shown to be expressed in horizontal, amacrine and Müller 
cells in the chicken retina (Tekmen-Clark and Gleason 2013). There are at least 15 
known types of nNOS-positive, NO-producing neurons in the chicken inner retina, 9 of 







Figure 1.2. Enzymatic NO production. Using L-arginine, the energy from NADPH, and 
oxygen, nitric oxide synthase synthesizes L-citrulline and NO. NO can then activate its 
canonical receptor soluble guanylate cyclase (sGC) and increase cGMP production. NO 
can also alter protein function by binding to a sulfhydryl group on cysteine residues.  
 
In the intact mouse retina, NO synthesis in the IPL is stimulated by both steady 
and flickering light (Blom et al. 2012). Activation of voltage-gated calcium channels 
(VGCCS) or Ca2+ permeable NMDA receptors (NMDARs) in ACs that express 
nNOS/eNOS will cause a transient rise of intracellular Ca2+, which can activate NOS 
and lead to synthesis of NO (Pang et al. 2010). Light-dependent production of NO also 
leads to S-nitrosylation (see below) of proteins throughout the retina, which could alter 
protein function (Tooker and Vigh 2015). The increase of NO production via light 
stimulation suggests that NO has a role in processing the visual signal.  A few functions 
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for NO have been determined including modulation of dopamine release (Sekaran et al. 
2005), uncoupling of horizontal cells (Daniels and Baldridge 2011; DeVries and 
Schwartz 1989; Lu and McMahon 1997; Pottek et al. 1997), blocking AII-cone bipolar 
coupling (Mills and Massey 1995; Xia and Mills 2004), and modulation of light 
responses (Kurenny et al. 1994; Levy et al. 2004; Sato et al. 2011). However, the full 
range of NO’s effect on retinal signaling remains unclear.  
Regulation of nNOS and eNOS 
 Although nNOS/eNOS activation is dependent on Ca2+/CaM association, 
additional mechanisms regulate nNOS/eNOS activity and subcellular localization. Post-
translational modifications such as phosphorylation, acylation and S-nitrosylation alter 
the function of nNOS/eNOS. Depending on the site, phosphorylation of nNOS/eNOS 
can either increase or decrease activity (Dimmeler et al. 1999; Michel et al. 1997; 
Rameau et al. 2003). Acylation (myristoylation and palmitoylation) attaches eNOS to the 
plasmalemmal caveolae membrane (Garcia-Cardena et al. 1996; Shaul 2002). 
Depalmitoylation of eNOS is due to prolonged exposure to its substrate, L-arginine, and 
is potentiated by Ca2+/CaM (Yeh et al. 1999). Depalmitoylation results in translocation of 
eNOS to other intracellular regions; one possible mechanism by which eNOS activity is 
regulated (Feron and Balligand 2006; Shaul 2002; Yeh et al. 1999). S-nitrosylation, as 
described below, can act as a negative feedback mechanism by inhibiting the function 
of NOS.  
Protein-protein interactions can also regulate NOS activity. Association with the 
caveolae scaffolding protein caveolin reversibly inhibits eNOS (Michel et al. 1997). 
Neuronal NOS can be anchored to the post-synaptic density protein-95 (PSD-95), which 
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links nNOS to NMDA receptors (Eldred and Blute 2005; Sattler et al. 1999). This can 
lead to quick activation of nNOS and NO synthesis when NMDA receptors are 
activated. CAPON, an adaptor protein, can regulate nNOS interactions with Dexras1, a 
small G protein of the Ras family (Jaffrey et al. 1998). NOSTRIN (eNOS trafficking 
inducer protein) is an adaptor protein that regulates internalization of eNOS towards 
intracellular compartments (Icking et al. 2005; Zimmermann et al. 2002). NOSIP (nitric 
oxide synthase interacting protein) inhibits nNOS production of NO by modifying nNOS 
localization and activity (Schleicher et al. 2005). Regulation of NOS activity by 
subcellular localization adds another level of complexity to the diverse functions of NO.   
Nitric oxide targets 
 There are several known targets of NO.  The most studied target is soluble 
guanylate cyclase (sGC), also known as the canonical “NO receptor” (Arnold et al. 
1977).  Soluble guanylate cyclase activation produces cyclic guanosine monophosphate 
(cGMP) and occurs when NO binds to the heme group of sGC. Cyclic GMP is a 
secondary messenger molecule that activates a serine/threonine kinase known as 
protein kinase G (Poulos 2006).  
 Nitric oxide can also have direct effects on proteins. S-nitrosylation occurs when 
a NO group is covalently attached to a thiol group located on cysteine residues (Figure 
1.2). Much like phosphorylation, S-nitrosylation can alter the function of a protein. 
Potential targets for S-nitrosylation include ryanodine receptors (Aracena-Parks et al. 
2006), G-protein coupled receptors (Estrada et al. 1997), cyclic nucleotide-gated ion 
channels (Broillet 2000), potassium channels (Asada et al. 2009; Kawano et al. 2009; 
Nunez et al. 2006), and transient receptor potential channels (Shimizu et al. 2014; 
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Takahashi et al. 2012; Yoshida et al. 2006).  In the retina, light-dependent NO 
production leads to S-nitrosylation of more than 300 identified proteins (Tooker and Vigh 
2015) 
Although work in the Gleason lab has been done on the postsynaptic effects of 
NO in ACs (Hoffpauir et al. 2006; Krishnan and Gleason 2015), the NO-synthesizing 
enzyme nNOS is located presynaptically at the electron microscopy level, and a 
presynaptic role for NO on AC neurotransmitter release had remained uninvestigated. 
Thus, I tested the hypothesis that NO can alter the release of GABA from ACs. The 
results presented here provide the first direct evidence that NO enhances spontaneous 
and evoked Ca2+-dependent GABA release from ACs. In Chapter 2, I explore the 
mechanism underlying the NO-dependent enhancement of GABA release from ACs.  
My work in this chapter was published in the Journal of Neurophysiology in 2017. In 
Chapter 3, I demonstrate that ACs in culture and in the adult retina express TRPC5 a 
Ca2+-permeable ion channel, and using a combination of pharmacology and a genetic 
knockdown strategy, I demonstrate that TRPC5 is required for the NO-dependent 
increase in dendritic Ca2+ and enhancement of GABA release.  
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NITRIC OXIDE PROMOTES GABA RELEASE BY ACTIVATING A  
VOLTAGE-INDEPENDENT CA2+ INFLUX PATHWAY  
IN RETINAL AMACRINE CELLS* 
 
Introduction 
Amacrine cells (ACs) are retinal interneurons that shape the visual signal in the 
inner retina via activity of their primarily glycinergic and GABAergic synapses.  Most 
ACs have mixed-use dendrites because they are sites of both synaptic input and 
synaptic output.  ACs form complex microcircuits by making reciprocal, lateral and serial 
inhibitory synapses with bipolar cells, ganglion cells and other ACs (Chavez et al. 2010; 
Grimes et al. 2010; Grimes et al. 2015; Tsukamoto et al. 2001).  These microcircuits are 
localized to AC dendrites, which can also have localized Ca2+ elevations (Euler et al. 
2002). 
Nitric oxide synthase (NOS) is a nitric oxide (NO) synthesizing enzyme that has 
two Ca2+-sensitive isoforms: endothelial NOS (eNOS) and neuronal NOS (nNOS).  Both 
enzymes have been localized to ACs as well as other retinal cell types (Fischer and 
Stell 1999; Haverkamp et al. 2000; Kim et al. 1999; Kim et al. 2000; Pang et al. 2010; 
Tekmen-Clark and Gleason 2013).  Neuronal NOS has also been localized to AC 
presynaptic terminals in the inner turtle retina (Cao and Eldred 2001), suggesting that 





*This chapter previously appeared as “Nitric oxide promotes GABA release by activating 
a voltage-independent Ca2+ influx pathway in retinal amacrine cells” J. Wesley Maddox 
and Evanna Gleason, Journal of Neurophysiology. Published 1 March 2017 Vol. 117 no. 
3, 1185-1199. DOI: 10.1152/jn.00803.2016. It is reprinted by permission of American 
Physiological Society. See Appendix for letter granting permission. 
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The major signaling mechanisms for NO are through the cGMP pathway via 
activation of the canonical NO receptor, soluble guanylate cyclase, and through the 
direct chemical modification of proteins via S-nitrosylation.  The light-dependent 
operation of both pathways appears to be widespread in the retina (Blom et al. 2012; 
Tooker and Vigh 2015).  Although NO is typically viewed as diffusible, NO imaging has 
demonstrated that NO is largely confined to cellular boundaries in multiple retina cell 
types including ACs (Eldred and Blute 2005; Tekmen-Clark and Gleason 2013).  This 
implies that NO-dependent mechanisms can be localized to NO-producing cells and to 
their immediate synaptic partners. 
The functions of NO in the retina are not fully known, but multiple sites of NO 
action have been identified.  NO production is stimulated under photopic illumination 
and is known to be involved in light adaptation.  For example, NO decouples horizontal 
cells (HCs) from other HCs (DeVries and Schwartz 1989; Miyachi et al. 1990) and 
decouples ON bipolar cells from A2 ACs (Mills and Massey 1995).  NO can also affect 
the ON and OFF pathways.  In retinal ganglion cells, NO reduces both ON and OFF 
light responses with the OFF responses being the most sensitive to NO (Wang et al. 
2003).  The mechanism underlying this inhibition of the pathway was not fully worked 
out, but the results pointed to an effect on neurons presynaptic to ganglion cells, most 
likely ACs.  Thus, AC synaptic function may be regulated by NO.  
To test the hypothesis that NO can alter synaptic output from ACs, we employed 
whole-cell current recordings and intracellular Ca2+ imaging in cultured chick ACs.  We 
found that the NO donor SNAP increased both spontaneous and evoked GABAergic 
neurotransmission due to a NO-dependent increase of cytosolic Ca2+.  We find that a 
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likely TRPC-mediated Ca2+ influx is required, however, Ca2+ release from stores is not 
required.  These data suggest that NO activates a presynaptic Ca2+ influx pathway that 
enhances GABAergic output from AC synapses in the retina.  
Methods 
Amacrine cell cultures 
The use of chick embryos to prepare retinal cultures was determined to be 
exempt by the LSU Institutional Animal Care and Use Committee.  Eight-day white 
leghorn (Gallus gallus) chick embryo retinas were removed from the eyecup and 
dissected free of the retinal pigment epithelium.  Retinas were initially dissociated in 
Ca2+- and Mg2+-free Hank’s solution (Life Technologies, Grand Island, NY).  The tissue 
was centrifuged (950 × g), and the supernatant replaced with 0.125% trypsin (Sigma-
Aldrich, St. Louis, MO).  The pellet was resuspended and incubated at 37 °C/5% CO2 
for 30 min.  After incubation and centrifugation (1,900 × g), the supernatant was 
replaced with Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies) 
supplemented with 5% fetal bovine serum (Sigma-Aldrich), penicillin (100 U/mL), 
streptomycin (100 µg/mL) and glutamine (2 mM) (Life Technologies).  Cells were plated 
at a density of 2.5 × 105 cells/35 mm dish that were pretreated with 0.01% poly-DL-
ornithine hydrobromide (Sigma Aldrich).  Cultures were fed every other day after initial 
plating by replacing half of the media with Neurobasal medium supplemented with 1% 
B-27, penicillin (100 U/mL), streptomycin (100 µg/mL) and glutamine (2 mM) (Life 
Technologies).  Experiments were performed on ACs that had been in culture for 8-13 
days (embryonic equivalent days 16 to 21). Over this time in culture, AC-to-AC 
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GABAergic synapses are functional.  ACs were identified on morphological criteria 
(Gleason et al. 1993).  
Electrophysiology 
Whole-cell voltage clamp recordings were performed using Axopatch 1D 
amplifier, Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular 
Devices, Sunnyvale, CA).  Patch pipette electrodes with a tip resistance between 5-10 
MΩ for ruptured-patch recordings or 3-5 MΩ for perforated-patch recordings were pulled 
from thick-walled borosilicate glass (1.5 mm O.D., 0.86 mm I.D.) using a P-97 
Flaming/Brown Puller (Sutter Instruments, Novato, CA).  A reference Ag/AgCl electrode 
pellet was placed in 3 M KCl and connected to the culture dish with a 3 M KCl agarose 
bridge.  Recordings were performed at room temperature (22-24°C).  A pressurized 
perfusion system (AutoMate Scientific, Berkeley, CA) was used to deliver external 
solutions at a flow rate of 1 mL/min.  Most recordings were performed on postsynaptic 
ACs whose processes were in contact with unclamped presynaptic ACs and that had 
spontaneous postsynaptic currents (sPSCs).   Variability of basal sPSC frequency 
depended on cell culture density. Denser cultures had higher basal sPSC frequency, 
possibly due to more synaptic sites.  Cells that did not have basal sPSCs also did not 
respond to the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP; Enzo, 
Farmingdale, NY) and were excluded from the analysis. Autaptic recordings were made 
from ACs that were not in contact with other ACs to eliminate the possibility that input 





All reagents were purchased from Sigma-Aldrich unless otherwise stated.  
Tetraethylammonium (TEA)-Cl external solution (in mM): NaCl (117), KCl (5.3), TEA-Cl 
(20), CaCl2 (3), MgCl2 (0.41), glucose (5.6), HEPES (10), pH 7.4.  LiCl (117) replaced 
NaCl in evoked autaptic experiments to block the Na+/Ca2+ exchanger current that can 
contaminate the autaptic currents at the end of the voltage step.  Rupture-patch high Cl- 
internal solution (in mM): CsCl (110), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), 
NaCl2 (1), ATP-2Na+ (3), ATP- 2K+ (1), GTP (2), phosphocreatine (20), creatine 
phosphokinase (50 U/mL), pH 7.4. Perforated-patch high Cl- internal solution (in mM): 
CsCl (145), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl (1), pH 7.4, 
amphotericin B (200 μg/mL).  Perforated-patch normal internal solution (in mM): Cs-
Acetate (135), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl (1), pH 7,4, 
Amphotericin B (200 μg/mL).  Typical reversal potential for Cl- (ECl-) in cultured ACs is 
~-80 mV to -60 mV, however, these high Cl- internal solutions increase the reversal 
potential of Cl- to 0 mV, increasing the driving force on Cl- and improving the resolution 
of quantal events.  High internal Cl- also blocks the NO-dependent release of Cl- 
(Hoffpauir et al. 2006).  While we have previously shown that the concentration of SNAP 
used here (500 μM) does not elicit Cl- release (Hoffpauir et al. 2006), this internal 
solution further ensures that the NO-dependent release of Cl- will not confound our 
results.  For imaging experiments, the following external solutions were used: Normal 
external solution (in mM): NaCl (137), KCl (5.37), CaCl2 (3), MgCl2 (0.41), glucose (5.6), 
HEPES (3.02), pH 7.4.  Zero Ca2+ external solution (in mM):  NaCl (141.5), KCl (5.37), 
MgCl2 (0.41), glucose (5.6), HEPES (3.02), pH 7.4. 
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Reagents  
The NO donor SNAP (500 μM; Enzo), the NO scavenger 2-[4-carboxyphenyl]-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO, 10 μM, Enzo), bicuculline (10 
μM), and TTX (300 nM; Abcam, Cambridge, MA) were dissolved directly into the 
external solution.  1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis 
(acetoxymethyl ester) (BAPTA-AM, 10 μM, Life Technologies) was prepared as a 10 
mM stock in DMSO.  The stock was diluted into Hank’s Balanced Salt Solution with 
NaHCO3 (HBSS), briefly vortexed and sonicated for 30 s.  Cells were incubated with 
BAPTA-AM at 37 ºC/5% CO2 for 45 minutes prior to recording.  1H-
[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 2 μM; Tocris, Bristol, UK), 2-
Aminoethoxydiphenylborane (2-APB, 20 μM; Tocris), 1-[2-(4-Methoxyphenyl)-2-[3-(4-
methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride (SKF 96365, 30 μM, Tocris), 
N-Ethylmaleimide (NEM, 300 μM; Sigma), 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-
3,5-pyridinedicarboxylic acid dimethyl ester (nifedipine, 20 μM; Tocris), 6-Cyano-7-
nitroquinoxaline-2,3-dione (CNQX, 50 μM), and 1-[(4-Chlorophenyl)methyl]-2-(1-
pyrrolidinylmethyl)-1H-benzimidazole hydrochloride (clemizole, 10 μM; Tocris) were 
prepared as 1000X stocks in DMSO and diluted to 1X in external solution.  D-(-)-2-
Amino-5-phosphonopentanoic acid (D-AP5, 10 μM; Tocris) was prepared as a 10 mM 
stock and diluted in external solution.  The sarco/endoplasmic reticulum Ca2+ ATPase 
(SERCA) pump inhibitor thapsigargin (TG; 2 µM; Enzo) was prepared as a 2 mM stock 
in DMSO and added directly to the culture media.  Cells were incubated with TG at 37 




The fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1, AM (OGB, 2 µM, 
Life Technologies) was prepared as a 2mM stock in DMSO.  OGB stock and Pluronic F-
127 (2.5% w/v in DMSO, Life Technologies) were mixed in a 1:1 ratio and sonicated.  2 
µL of the OGB/Pluronic mixture was diluted in 1 mL of Hank’s buffered salt solution 
(HBSS) then briefly vortexed and sonicated for 30 s.  Cells were incubated with the 
HBSS/OGB/Pluronic mixture for 1 hr at room temperature (22-24°C).  
HBSS/OGB/Pluronic mixture was replaced with normal external solution.  Images were 
taken every 500 ms (200 ms exposure), 3 s (400 ms exposure), or 6 s (200 ms 
exposure).  To obtain data relevant to synaptic function, regions of interest (ROIs) were 
chosen at sites of contact between processes.  Images were captured on an inverted 
Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke, Kelheim, 
Germany).  Data were collected and analyzed using Slidebook software (Intelligent 
Imaging Innovations, Denver, CO).  In all Ca2+ imaging experiments, the control 
fluorescence mean was calculated by using the average of the last 10 ROI time points 
before switching solutions, and the fluorescence means after switching solutions were 
calculated by using the 10 ROI time points from the middle of each solution application. 
The control and different solution fluorescence means were used to calculate percent 
change in fluorescence. 
Data analysis 
For sPSC electrophysiology experiments, Mini Analysis Program (Synaptosoft, 
Inc, Fort Lee, NJ) was used to detect and analyze sPSCs.  Quantal event kinetics were 
analyzed using data from cells that were only exposed to SNAP.  Multiquantal events 
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were removed from analysis by determining the mean and SD of the rise time of quantal 
events from control data where multiquantal events are extremely rare.  Quanta with a 
rise time longer than 3.7 ms (mean rise time plus one SD) were excluded from the 
analysis. Mean amplitudes (pA), mean rise times (ms) and mean decay times (ms) were 
determined from each of the 9 recorded cells during control (254 total events) and 
application of SNAP (319 total events, 489 multiquantal events removed). Mean 
amplitude, mean rise time and mean decay time from each cell were used for statistical 
analysis.  Charge transfer integration and Ca2+ current leak subtraction was performed 
using OriginPro (OriginLab, Northampton, MA). Charge transfer was calculated by 
integrating the area under the post-depolarization autaptic current waveform.  The 
charge transfer integration (pA*s) was then calculated and reported as pC.  After linear 
leak subtraction, activation voltage of voltage-gated Ca2+ channels was measured at the 
point the Ca2+ current reached 5% of the maximum current amplitude.  In autaptic and 
voltage-ramp experiments, perforated-patch configuration using amphotericin B (Sigma) 
was used to maintain the native presynaptic environment as much as possible during 
prolonged recording times.  Because amphotericin B introduces an unknown liquid 
junction potential, voltages were left uncorrected.  Statistics were performed using 
GraphPad Prisim 6 (GraphPad Software, La Jolla, CA).  Repeated Measures-ANOVA 
with Fisher’s Least Significant Difference (LSD) post hoc analysis was performed on all 






SNAP increases sPSC frequency 
To determine whether NO affects spontaneous neurotransmitter release, ACs 
bearing processes in contact with other (unclamped) ACs were voltage clamped at -70 
mV in TEA-Cl external solution.  For spontaneous postsynaptic current (sPSCs) 
recordings, high-Cl- internal solution was used to increase the driving force on Cl- (at -70 
mV).  Under control conditions, sPSCs corresponding to quantal events were observed 
ranging in frequency from 1.4 to 77.6 events/30 s.  When SNAP (500 μM) and the NO 
scavenger CPTIO (10 μM) were co-applied, no change in sPSC frequency was 
observed (control, 9.8 ± 3/30 s, SNAP/CPTIO, 10.7 ± 3/30 s, P = 0.5, n = 8, Figure 2.1).  
When CPITO was removed and only SNAP was present, however, there was a 108% 
increase in sPSC frequency (SNAP/CPTIO, 10.7 ± 2.7/30 s, SNAP, 22.3 ± 5.2/30 s, P = 
0.03, n = 8, Figure 2.1).  NO did not affect the quantal event amplitude (control, 11.6 ± 
0.8 pA, SNAP, 11.3 ± 1.2 pA, P = 0.63, n = 9 cells, paired t-test), rise time (control, 2.3 ± 
0.1 ms, SNAP, 2.5 ± 0.1 ms, P = 0.12, n = 9 cells, paired t-test), or decay time (control, 
9.55 ± 1.1 ms, SNAP, 9.9 ± 1.2 ms, P = 0.86, n = 9 cells, paired t-test).  Thus, these 
data indicate that NO, rather than the donor molecule or NO metabolites, increased 
presynaptic spontaneous vesicle fusion and neurotransmitter release but did not affect 
the postsynaptic receptors. 
NO-dependent increase of sPSC frequency does not require soluble guanylyl cyclase 
(sGC) activity 
 
The canonical receptor for NO is sGC, and NO-activated sGC increases the 
production of the secondary messenger cGMP.  To determine if NO-dependent 











Figure 2.1. NO increases frequency of spontaneous postsynaptic currents (sPSCs). A: 
recording from a representative postsynaptic AC voltage clamped at -70 mV and 
synaptically connected with other unclamped ACs. Co-application of the NO donor SNAP 
(500 µM) and the NO scavenger CPTIO (10 µM) had no effect on the sPSC frequency. 
After removal of CPTIO, a significant increase sPSC frequency was observed. 
*Multiquantal events. B: quantified mean event frequency of sPSCs/30 s SE; n = 8. **P < 
0.01 (repeated measures-ANOVA).  
 
cells were pre-incubated with the sGC inhibitor ODQ (2 μM) for 12 minutes prior to 
recording, and ODQ remained throughout the recording.  Even in the presence of ODQ, 
SNAP caused a 173% increase in sPSC frequency (ODQ, 20.1 ± 4.5/30 s, ODQ/SNAP, 
54.9 ± 15.0/30 s, P = 0.03, n = 12, Figure 2.2).  Acute application of ODQ alone did not 
alter sPSC frequency (control, 6.6 ± 3.19/30 s, ODQ, 5.25 ± 2.8/30s, P = 0.06, n = 4, 
paired t-test).  These data suggest that sGC does not mediate the NO-dependent 
increase in sPSC frequency.  
Because activation of the canonical NO receptor sGC is not required for the 
increase in sPSC frequency, we investigated the role of another NO signaling pathway, 
S-nitrosylation that occurs when NO reacts with a cysteine residue thiol group to form a 
S-nitrosothiol.  S-nitrosylation posttranslational protein modification is similar to 










Figure 2.2.  NO-dependent increase of sPSCs does not require soluble guanylate cyclase 
(sGC) activity.  A: Recording from a representative AC held at -70 mV.  Cells were 
exposed to the sGC inhibitor ODQ (2 µM) for at least 12 minutes prior to and throughout 
the recordings.  SNAP increased the frequency of sPSCs in the presence of ODQ.  B: 
Quantified mean event frequency of sPSCs/30 s ± SE, n = 12. *P < 0.05 (paired t-test). 
 
 
(NEM), a known inhibitor of S-nitrosylation, was used to investigate if S-nitrosylation 
was involved in the NO-dependent increase in sPSC frequency.  NEM (300 µM), 
however, caused an increase in sPSC frequency from baseline by 411% (control, 24.2 ± 
15.26/30 s, NEM, 123.5 ± 26.78/30 s, P = 0.007, n = 7, paired t-test).  Unfortunately, 
NEM has multiple targets including presynaptic proteins (Clary et al. 1990; Peters et al. 
1990; Rothman 1996) and has been shown to increase GABAergic spontaneous 
neurotransmitter release (Kirmse and Kirischuk 2006; Knight et al. 2004) and activate 
some Ca2+ channels (Bindoli and Fleischer 1983; Graham et al. 2010; Pan et al. 2011). 
These results precluded further experiments using NEM in this study. 
NO-increases GABAergic sPSC frequency 
Cultured ACs used in the present study have been demonstrated to be 
GABAergic (Gleason et al. 1993).  However, to confirm that NO is promoting the release 
of GABA rather than an additional neurotransmitter, the ionotropic GABA receptor 
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antagonist bicuculline (10 μM) was added to the extracellular solution during the 
application of SNAP.  SNAP caused a 190% increase in sPSC frequency (control, 7.6 ± 
2.0/30 s to SNAP, 22.1 ± 5.7/30 s, P = 0.02; n = 9, Figure 2.3A-B).  However, 
bicuculline caused a 99% reduction in NO-dependent sPSC frequency (SNAP, 22.1 ± 
5.7/30 s, SNAP/bicuculline, 0.3 ± 0.1/30 s, P = 0.003, n = 9, Figure 2.3A-B).  These data 
indicate that NO increased GABAergic sPSCs due to increased presynaptic vesicle 
fusion and GABA release, but not due to the release of any other neurotransmitter.  
Previous work from our lab demonstrated a small (~15%) NO-dependent enhancement 
of whole-cell GABAA receptor currents, apparently due to an alteration in channel 
function (Hoffpauir et al. 2006).  Here, we see no effect of NO on sPSC current 
amplitude, suggesting that synaptic and extra-synaptic receptors may be differentially 
regulated.  
NO-dependent increase of sPSC frequency is not action potential-dependent 
Some ACs are known to fire action potentials (Cook et al. 1998; Heflin and Cook 
2007; Watanabe et al. 2003).  For the experiments recording sPSCs (Figures. 2.1-3A), 
presynaptic ACs were unclamped, which allows their membrane potentials to fluctuate 
and possibly produce action potentials.  To determine whether the NO-dependent 
increase of GABA release was due to presynaptic action potentials in response to NO, 
the voltage-gated Na+ channel blocker tetrodotoxin (300 nM, TTX) was included in the 
TEA-Cl external solution.  In the presence of TTX, SNAP still elicited a 202% increase in 
sPSC frequency (TTX, 7.3 ± 2.0/30 s, TTX/SNAP, 22.1 ± 5.7/30 s, P = 0.03, n = 5, 
paired t-test, Figure 2.3C-D).  This indicates that sPSC frequency was increased by a 














Figure 2.3.  NO-induced increase in GABAergic sPSC frequency does not require action 
potentials.  A: Recording from a representative postsynaptic AC held at -70 mV.  
Application of the NO donor SNAP increased the frequency of sPSCs.  Addition of the 
GABAA receptor antagonist bicuculline abolished the NO-dependent increase of sPSCs, 
indicating that these are GABAergic sPSCs.  B: Quantified mean event frequency of 
sPSCs/30 s ± SE, n = 9. *P < 0.05, **P < 0.01 (repeated measures-ANOVA).  C: Voltage 
clamp recording from a representative postsynaptic AC held at -70 mV.  SNAP increased 
the frequency of sPSCs in the presence of the voltage-gated Na+ channel blocker TTX 
(300 nM).  D: Quantified mean event frequency of sPSCs/30 s ± SE, n = 5. *P < 0.05 
(paired t-test). 
 
Vesicle fusion and neurotransmitter release depends on the local presynaptic 
Ca2+ concentration.  To determine whether NO affects cytosolic Ca2+, cytosolic Ca2+ 
levels were monitored using the fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1 
(OGB, 2 μM).  Data were collected from regions of neuronal process contacts, 
potentially synaptic sites.  Co-application of the NO scavenger CPTIO and SNAP did 













Figure 2.4.  NO increases intracellular Ca2+.  A: Calcium imaging of AC processes loaded 
with Oregon Green BAPTA-1 488, AM, revealed that NO caused an increase of 
intracellular Ca2+ at potential synaptic sites.  When the NO donor SNAP (500 μM) and 
NO scavenger CPTIO (10 μM) were co-applied, there was no significant increase in 
intracellular Ca2+ (P > 0.15).  Removal of CPTIO was followed by a significant increase in 
cytosolic Ca2+. Note that mean fluorescence in A is larger because data were collected 
with longer exposure times (400 ms) than all other data (200 ms).  B: Quantified mean 
peak fluorescence ± SE in (A), n = 57. ****P < 0.0001 (repeated measures-ANOVA).  C: 
Intracellular Ca2+ is reduced when extracellular Ca2+ is removed (0 Ca2+ext) even in the 
presence of SNAP.  D: Quantified mean peak fluorescence ± SE in (C) showing that 
SNAP caused a significant increase in fluorescence and that removing extracellular Ca2+ 
(0 Ca2+ext) significantly reduced the fluorescence, n = 35. ****P < 0.0001 (repeated 
measures-ANOVA).  Fluorescence over time data are plotted as mean fluorescence ± 
SE. 
 
of CPTIO, however, there was a 32% increase in intracellular Ca2+ (CPTIO/SNAP, 
26.7± 1.2 AU, SNAP, 35.3 ± 1.6 AU, p < 0.0001, n = 57, Figure 2.4A-B).  Additionally, 
there was an 11% reduction in cytosolic Ca2+ when external Ca2+ was removed during 
the SNAP application, (SNAP, 7.9 ± 0.5 AU, SNAP/0 Ca2+, 7.0 ± 0.4 AU, p < 0.0001, n = 
35, Figure 2.4C-D).  These results indicated that NO, rather than the donor molecule or 
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NO metabolites, increased intracellular Ca2+ via an extracellular Ca2+-dependent 
mechanism. 
The role of Ca2+ 
Having established that NO can produce Ca2+ elevations in ACs, we asked 
whether the Ca2+ elevations were driving the NO-dependent increase in sPSCs.  
BAPTA-AM (10 µM), a cell-permeant fast Ca2+ chelator, was loaded into the cells prior 
to recordings.  In BAPTA-containing cells, sPSC frequency in the recorded cell was not 
enhanced by SNAP (control, 5.9 ± 1.1/30 s, SNAP, 6.4 ± 1.1/30 s, P = 0.62, n = 12, 
paired t-test, Figure 2.5B-C).  In cells that did not have BAPTA, however, SNAP caused 
a 172% increase in sPSC frequency (control, 9.2 ± 1.3/30 s, SNAP, 25.0 ± 2.7/30 s, P = 
0.0002, n = 12, paired t-test, Figure 2.5A-C).  These results suggest that the NO-
dependent increase in intracellular Ca2+ is responsible for the NO-dependent increase 
in sPSC frequency.   
To determine if Ca2+ influx, specifically, is involved in the NO-dependent increase 
of sPSCs, extracellular Ca2+ was removed during the application of SNAP.  Prior to Ca2+ 
removal, SNAP caused a 61% increase in sPSC frequency (control, 19.4 ± 8.8/30 s, 
SNAP, 31.2 ± 12.7/30 s, P = 0.03, n = 8, Figure 2.5D-E).  When extracellular Ca2+ was 
removed during SNAP application, there was a 62% reduction in sPSC frequency 
(SNAP, 31.2 ± 12.7/30 s, SNAP/0 Ca2+, 11.9 ± 7.1/30 s, P = 0.02, n = 8, Figure 2.5D-E).  
These results indicate that Ca2+ influx is required for the NO-dependent increase of 
sPSC frequency. 
Ca2+ stores can play a role in vesicle fusion and GABA release in ACs (Chavez 

















Figure 2.5.  The NO-dependent increase of sPSC frequency is dependent upon cytosolic 
Ca2+ elevations.  A,B: Representative recordings from postsynaptic ACs voltage clamped 
at -70 mV.  A: The NO donor SNAP was able to increase sPSC frequency under control 
conditions (No BAPTA). B: In BAPTA loaded ACs (+ BAPTA), however, SNAP did not 
increase sPSC frequency.  C: Quantified mean event frequency/30 s ± SE. Cells 
containing BAPTA did not experience an NO-dependent increase in sPSC frequency (n 
= 12 for each group).  ***P < 0.001 (paired t-test).  D: Recording from a representative 
AC held at -70 mV.  After the removal of extracellular Ca2+ (0 Ca2+ext), NO is no longer 
effective in increasing the frequency of sPSCs.  E: Quantified mean frequency of 
sPSCs/30 s ± SE, n = 8. *P < 0.05 (repeated measures-ANOVA). 
 
stores to the NO-dependent increase in cytosolic Ca2+ was investigated in OGB-loaded 
ACs that were pre-incubated with the SERCA pump inhibitor thapsigargin (TG, 2µM, 1 
hr).  The effectiveness of this treatment in emptying the Ca2+ store was evaluated by 
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perfusing caffeine (20 mM) to release store Ca2+.  For control cells in zero Ca2+ external 
solution (0 Ca2+ext), caffeine reliably produced rapid increases in cytosolic Ca2+ at 
contact points between processes (0 Ca2+ext, 12.33 ± 1.21 AU, 0 Ca2+ext and caffeine, 
13.52 ± 1.14 AU, P = 0.004, n = 25, Figure 2.6A,C).  However, cells pretreated with TG 
did not produce caffeine-dependent Ca2+ elevations, indicating depletion of the Ca2+ 
store (Figure 2.6B,D).  Using this same TG pretreatment protocol, the effect of SNAP on 
cytosolic Ca2+ was examined.  Under normal external Ca2+ conditions, SNAP elicited a 
15% and 9% Ca2+ elevation in both control (control, 6.2 ± 0.4 AU, SNAP, 7.1 ± 0.5 AU, p 
< 0.0001, n = 50, paired t-test, Figure 2.6E,G) and TG-treated (control, 9.4 ± 1.3 AU, 
SNAP, 10.2 ± 1.2 AU, p < 0.0001, n = 17, paired t-test,  Figure 2.6F,H) cells, 
respectively.  TG-treated cells produced no NO-dependent Ca2+ elevations in the 
absence of extracellular Ca2+ (0 Ca2+, 6.9 ± 0.3 AU, 0 Ca2+/SNAP, 6.8 ± 0.3 AU, P = 
0.06, n = 107, Figure 2.6I,J).  These data show that under these conditions NO elicits 
Ca2+ elevations by activating a Ca2+ influx pathway exclusively. 
To confirm that Ca2+ stores do not play a role in the NO-dependent increase of 
sPSCs, voltage clamp recordings were made from ACs pre-incubated in TG. SNAP still 
caused a 65% and 171% increase in sPSC frequency in TG-treated (control, 18.3 ± 
5.3/30 s, SNAP, 30.2 ± 6.1/30 s, P = 0.003, n = 8, paired t-test, Figure 2.7B-C) and in 
control (control, 10.1 ± 4.1/30 s, SNAP, 27.4 ± 8.3/30 s, P = 0.034, n = 4, paired t-test, 
Figure 2.7A,C) cells, respectively.  These results confirm that NO increases GABAergic 
sPSC frequency by activating a plasma membrane Ca2+ influx pathway that is 


















Figure 2.6.  NO-dependent increase of intracellular Ca2+ is independent of intracellular 
stores.  A: In the absence of extracellular Ca2+ (0 Ca2+ext), caffeine (20 mM) produced a 
rapid and transient increase in intracellular Ca2+ when thapsigargin (TG) was not present.  
B: For cells pre-incubated in TG (2 μM, 1 hr), no caffeine-dependent store release was 
observed. C,D: Quantified mean fluorescence ± SE in A (n = 25) and B (n = 37), 
respectively.  E, F: The NO donor SNAP produced an increase in intracellular Ca2+ in 
both control and thapsigargin-treated AC processes.  G,H: Quantified mean fluorescence 
± SE in E (n = 50) and F (n = 107), respectively.  I: The NO donor SNAP does not increase 
intracellular Ca2+ in the presence of TG and the absence of extracellular Ca2+.  J: 
Quantified mean fluorescence ± SE in I (n = 107).  Images were taken every 500 ms in 
A-B, and every 6 s in E-F, I. *P < 0.05, ***P < 0.001, ****P < 0.0001, nsP > 0.57 (repeated 















Figure 2.7.  NO-dependent increase of sPSC frequency is independent of Ca2+ stores.  
A,B: Representative recordings from postsynaptic amacrine ACs held at -70 mV without 
(A) or with (B) pre-incubation with TG (2 µM, 1 hr).  The NO-dependent increase of sPSC 
frequency persisted in the presence of TG.  C: Quantified mean event frequency/30 s ± 
SE.  Addition of SNAP increased sPSCs in cells with intact Ca2+ stores (No TG, n = 4) 
and after Ca2+ store depletion (+TG, n = 8).  *P < 0.05, **P < 0.01 (paired t-tests). 
 
NO increases evoked GABAergic autaptic transmission 
In the retina, ACs receive excitatory signals from bipolar cells.  Depolarization of 
ACs leads to evoked neurotransmitter release onto postsynaptic cells, which can be 
bipolar cells, ganglion cells or other ACs.  To determine the role of NO in evoked 
neurotransmitter release, perforated patch whole-cell recordings were performed on 
isolated ACs making autapses.  Cells were depolarized from -70 mV to -20 mV for 50 
ms to activate voltage-gated Ca2+ channels (VGCCs) and subsequently cause vesicle 
fusion and neurotransmitter release. The autaptic currents persisting after the voltage 
step were quantified.  SNAP caused a 51% increase in charge transfer (control, 177.0 ± 
47.6 pC, SNAP, 268.1 ± 59.7 pC, P = 0.03, n = 6, Figure 2.8A-B).  Bicuculline blocked 
the NO-dependent increase of the charge transfer (bicuculline, 48.2 ± 13.4 pC, 
	 34 
bicuculline/SNAP, 53.1 ± 16.3 pC, P = 0.32, n = 5, Figure 2.8C-D).  Note that the 
apparent SNAP-dependent change in the Ca2+ current amplitude during the voltage-
step is due to the contamination from inward GABA-gated current (Figure 2.8A), an 
effect that is absent in the presence of bicuculline (Figure 2.8C).  The sPSC frequency 
was also elevated during the SNAP application (Figure 2.8A inset). These data suggest 
that NO increases evoked GABAergic neurotransmission, possibly due to additive 
effects of two Ca2+ influx pathways being activated (NO-dependent Ca2+ influx and 
voltage-dependent Ca2+ influx) simultaneously. 
The effect of NO on sPSCs does not involve L-type VGCCs, AMPARs or NMDARs 
L-type VGCCs have been demonstrated to mediate neurotransmitter release 
between these cultured ACs (Gleason et al. 1993) and other AC synapses in the retina 
(Habermann et al. 2003; Vigh and Lasater 2004).  It has also been demonstrated that 
NO can activate retinal ganglion cell Ca2+ channels (Hirooka et al. 2000) and augment 
neuronal L-type Ca2+ currents (Tozer et al. 2012).  To determine if NO influences the 
voltage-gated Ca2+ current or activation voltage, voltage ramps from -90 mV to +50 mV 
were delivered in the presence of TTX (300 nM) and bicuculline (10 μM) to isolate the 
Ca2+ current.  In these experiments, perforated-patch normal internal solution and TEA-
Cl external solution were used.  Addition of SNAP did not change the Ca2+ current 
amplitude (control, -268.9 ± 45.1 pA, SNAP, -261.2 ± 43.8 pA, P = 0.45, n = 9, Figure 
2.9A) or the Ca2+ channel activation voltage (control, -45.36 ± 1.1 mV, SNAP, -45.13 ± 
0.73 mV, P = 0.69, n = 9).  Additionally, the L-type VGCC inhibitor nifedipine (20 µM) did 
not prevent the NO-dependent increase in sPSC frequency (nifedipine, 20.40 ± 4.2/30 


















Figure 2.8.  NO increases evoked autaptic GABAergic postsynaptic currents.  A: 
Recording from a representative AC depolarized from -70 mV to -20 mV for 50 ms.  
Evoked autaptic currents were increased after the addition of the NO donor SNAP.  Inset: 
sPSC frequency was elevated between depolarizations during the application of SNAP.  
B: Quantified mean charge transfer ± SE, n = 6.  *P < 0.05 (paired t-test).  C: Recording 
from a representative AC depolarized from -70 mV to -20 mV for 50 ms.  Addition of the 
GABAA receptor antagonist bicuculline blocked the NO-dependent increase of charge 
transfer.  D: Quantified mean charge transfer ± SE.  The NO donor SNAP did not 
significantly alter the evoked autaptic currents in the presence of bicuculline, n = 5.  P > 
0.3, (paired t-test). 
 
dependent increase in sPSC frequency remained unchanged after removal of nifedipine 
and leaving only SNAP in the bath (nifedipine/SNAP, 37.65 ± 6.07/30 s, SNAP, 40.3 ± 
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8.98/30 s, P = 0.78, n = 5, Figure 2.9B-C). These results demonstrate that L-type 
VGCCs are not involved.  The possibility that NO could activate AMPA and/or NMDA 
glutamate receptors (AMPARs and NMDARs) was investigated using Ca2+ imaging.  
The AMPAR and NMDAR antagonists CNQX (50 µM) and D-AP5 (10 µM), respectively, 
were applied before and during the application of SNAP. While AMPRs and NMDARs 
were blocked, NO increased intracellular Ca2+ by 10.8% (D-AP5/CNQX, 8.1 ± 0.3 A.U., 
D-AP5/CNQX and SNAP, 8.9 ± 0.4 A.U., n = 152 ROIs, p < 0.0001, Figure 2.9D).  
When D-AP5 and CNQX were removed, intracellular Ca2+ remained elevated (D-
AP5/CNQX and SNAP, 8.9 ± 0.4 A.U., SNAP, 9.1 ± 0.4 A.U., n = 152 ROIs, P = 0.1, 
Figure 2.9D).  These results show that NO does not activate L-type VGCCs, AMPARs 
or NMDARs.  Therefore, NO must be activating another plasma membrane Ca2+ influx 
pathway to admit extracellular Ca2+ presynaptically and to increase sPSC frequency.  
Clemizole blocks the NO-dependent increase in sPSC frequency and intracellular Ca2+ 
Previous work in our lab demonstrated that these amacrine cells contain mRNA 
for TRPC subunits 1, 3, 4, 5, 6, and 7 (Crousillac et al. 2003), and TRPC channels can 
be activated via S-nitrosylation (Yoshida et al. 2006).  To explore the possible role of 
TRPC channels in the NO-dependent increase in sPSC frequency, we used two 
traditional TRPC inhibitors, 2-APB and SKF 96365.  These inhibitors, however, have 
multiple documented effects on other ion channels, some of which conduct Ca2+ 
(DeHaven et al. 2008; Hong et al. 1994; Hotta et al. 2005; Leung et al. 1996; Merritt et 
al. 1990; Prakriya and Lewis 2001; Singh et al. 2010; Usmani et al. 2010; Wang 2003). 
Bath perfusion of 2-APB (20 µM) alone increased sPSC frequency from baseline by 














Figure 2.9. L-type voltage-gated Ca2+ channels (VGCCs), AMPARs or NMDARs are not 
required for the NO-dependent Ca2+ influx.  A: Voltage clamp recording from a 
representative AC ramped from -90 mV to 50 mV.  The NO donor SNAP (500 µM) did not 
affect the activation voltage or the peak of the Ca2+ current.  Bicuculline and TTX were 
included in the TEA-Cl external solution to isolate the Ca2+ current.  B: Current recording 
from a representative amacrine cell voltage clamped at -70 mV.  SNAP still increased 
sPSC frequency in the presence of the L-type VGCC inhibitor nifedipine (Nif, 20 µM). 
sPSC frequency was unchanged after removal of Nif. C: Quantified mean event 
frequency/30 s ± SE, n = 5.  *P < 0.05 (repeated measures-ANOVA). D: The NO-
dependent influx of Ca2+ still occurred in the presence of the NMDAR inhibitor D-AP5 (10 
µM) and the AMPAR inhibitor CNQX (50 µM). Data are Mean fluorescence (A.U.) ± SE, 
n = 152 ROIs. ****P < 0.0001 (repeated measures-ANOVA). 
 
and application of SKF 96365 (30 µM) alone increased sPSC frequency from baseline 
by 431% (control, 33.4 ± 7.5/30 s, SKF 96365, 177.4 ± 44.3, P = 0.044, n = 4, paired t-
test).  To avoid these confounding effects, clemizole (10 µM), a more specific TRPC 
channel blocker (with highest selectivity for TRPC5), was utilized to investigate TRPC 
channel involvement in the NO-dependent response. In the presence of clemizole, 
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SNAP was unable to increase sPSC frequency (control, 17.2 ± 3.7/30 s, 
clemizole/SNAP, 17.9 ± 2.0/30 s, P = 0.84, n = 10, Figure 2.10A-B). When clemizole 
was removed, SNAP increased sPSC frequency by 203% (clemizole/SNAP, 17.9 ± 2/30 
s, SNAP, 54.1 ± 16.8/30s, P = 0.04, n = 10, Figure 2.10A-B).  Additionally, SNAP was 
unable to increase process intracellular Ca2+ in the presence of clemizole (clemizole, 
5.7 ± 0.4 A.U., clemizole/SNAP, 5.7 ± 0.4 A.U., P = 0.45, n = 46 ROIs, Figure 2.10C-D). 
When clemizole was removed, SNAP increased intracellular Ca2+ by 7% 
(clemizole/SNAP, 5.7 ± 0.4 A.U., SNAP, 6.1 ± 0.4 A.U., p < 0.0001, n = 46, Figure 
2.10C-D).  Clemizole is also able to block H1 histamine receptors (Aguilar et al. 1986).  
It has been demonstrated that these receptors are functionally expressed in rodent 
dopaminergic amacrine cells and that their activation can engender Ca2+ elevations 
(Frazao et al. 2011; Gastinger et al. 2006). Although the amacrine cells in our cultures 
are GABAergic, we tested whether histamine (10 µM and 100 µM) produced Ca2+ 
elevations.  We found that Ca2+ elevations were not elicited by 10 µM histamine 
(control, 5.09 ± 0.25 A.U., 10 µM histamine, 5.05 ± 0.26 A.U., P = 0.16, n = 48) or 100 
µM histamine (control, 4.05 ± 0.12 A.U., 100 µM histamine, 4.07 ± 0.12 A.U., P = 0.19, 
n = 216) suggesting that either histamine receptors are not expressed or that their 
activation is not linked to an increase in cytosolic Ca2+.  Together, these results provide 
evidence that NO increases GABA release from amacrine cells by activating a TRPC-






















Figure 2.10.  Clemizole blocks the NO-dependent increase in sPSC frequency and 
intracellular Ca2+.  A: Current recording from a representative amacrine cell voltage 
clamped at -70 mV. Application of the TRPC inhibitor clemizole (clem, 10 µM) and co-
application of clem and the NO donor SNAP (500 µM) did not alter sPSC frequency. 
Removal of clem from the bath leaving only SNAP caused an increase in sPSC frequency. 
B: Quantified mean event frequency/30 s ± SE, n = 10. *P < 0.05 (repeated measures-
ANOVA). C: SNAP was unable to increase intracellular Ca2+ during the application of 
clem, however, SNAP increased intracellular Ca2+ upon removal of clem.  D: Quantified 
mean fluorescence ± SE, n = 46. ****P < 0.0001, (repeated measures-ANOVA).  
Fluorescence over time data are plotted as mean fluorescence ± SE. 
 
Discussion 
 These results demonstrate that NO promotes neurotransmitter release at 
GABAergic synapses in retinal amacrine cells (ACs).  We find that this action of NO is 
not dependent on presynaptic action potentials or sGC activity, however, it is dependent 
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upon an elevation in cytosolic Ca2+.  Both NO-dependent Ca2+ elevations and NO-
dependent increases in sPSCs were unaffected by store depletion, indicating that Ca2+ 
influx alone mediates the effects of NO.  Evoked GABA release was also enhanced in 
the presence of NO, but the activation of voltage-gated Ca2+ channels (VGCCs) was 
unaffected by NO.  Together, these observations imply that during evoked release, the 
NO-dependent Ca2+ elevations can add to the voltage-dependent Ca2+ elevations to 
enhance the evoked release of GABA. This interpretation is consistent with the steep 
dependence of evoked neurotransmitter release on Ca2+ (Augustine and Charlton 1986; 
Dodge and Rahamimoff 1967; Reid et al. 2003). Blocking TRPC channels using 
clemizole prevented the NO-dependent increase in sPSC frequency and intracellular 
Ca2+.  These results suggest that NO activates a TRPC-mediated Ca2+ influx pathway 
that is sufficient to drive synaptic exocytosis.  
VGCC-independent GABA release 
Other mechanisms of VGCC-independent GABA release have been 
demonstrated in ACs.  Chavez et al. (2006) showed that in the rat retina, reciprocal 
GABAergic synapses from A17 ACs onto bipolar cells can be directly stimulated by the 
activation of Ca2+-permeable AMPA receptors.  Voltage-independent GABA release 
was also demonstrated for cultured chick ACs via activation of metabotropic glutamate 
receptor 5 (Warrier et al. 2005).  Both mechanisms involved amplification through 
release of Ca2+ from stores.  Additionally, a study of unstimulated GABA release from 
cultured rat ACs demonstrated the involvement of both Ca2+ influx and store release (Ke 
et al. 2010).  The NO-dependent increase in sPSCs reported here is novel because our 
results argue against a contribution from stores.  
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NO and GABA release 
In agreement with our finding in cultured ACs, experiments measuring the levels 
of a GABA analog loaded in slices of turtle retina showed that NO promoted GABA 
release from ACs as well as horizontal cells (Yu and Eldred 2005).  Significantly, in the 
inner retina where ACs signal, the NO-dependent increase in GABA release was largely 
Ca2+-dependent and soluble guanylate cyclase-independent, consistent with what we 
find for cultured ACs.  NO has also been reported to stimulate GABA release from 
GABAergic cells in the ganglion cell layer (most likely displaced ACs) (Maggesissi et al. 
2009) in the intact chicken retina, although the underlying mechanism was not 
investigated.  Previous studies measuring the effects of NO on GABA release at other 
central synapses have demonstrated both enhancement (Merino et al. 2014; Tarasenko 
et al. 2014) and inhibition (De Laurentiis et al. 2000; Wall 2003).  In studies of the 
effects of NO on GABAergic sPSC frequency specifically, both increases in sPSC 
frequency (Li et al. 2004; Li et al. 2002; Xing et al. 2008; Yang and Cox 2007) and 
decreases in sPSC frequency (Lee 2009) have been reported for central mammalian 
synapses. Both effects can be dependent upon soluble guanylate cyclase activity (Lee 
2009; Yang and Cox 2008: Li et al. 2004).  Here, we show that GABAergic sPSC 
frequency is enhanced by NO via a soluble guanylate cyclase-independent mechanism.  
Together, these studies establish that the effects of NO on GABAergic signaling can be 
functionally and mechanistically diverse, indicating that the effects of NO on the 




Role of spontaneous GABA release 
There is abundant evidence that spontaneous and action potential (AP) evoked 
vesicular neurotransmitter release occur by distinct processes that involve different Ca2+ 
sensitivities, molecular machinery and synaptic vesicle pools (Kavalali 2015; Smith et al. 
2012). This existence of a parallel and similarly complex system of neurotransmitter 
release implies that spontaneous release has distinctive functions. One emerging role is 
in the regulation of the synapse itself.  Most is known about the role of spontaneous 
glutamate release in regulating synaptic function, however, recent work has 
demonstrated that spontaneous GABA release regulates synaptic scaling in the 
embryonic chick spinal cord (Garcia-Bereguiain et al. 2016).  The mechanism 
underlying this action of GABA depends on the depolarizing effect of GABA at that time 
in development, and scaling is achieved by adjusting the level of postsynaptic Cl-.  We 
have previously demonstrated that NO can release Cl- from an internal store and 
transiently convert inhibitory GABAergic synapses into excitatory GABAergic synapses 
(Hoffpauir et al. 2006; Krishnan and Gleason 2015).  Thus, the ability of GABA to even 
transiently generate depolarization-dependent Ca2+ elevations opens the possibility that 
NO-dependent spontaneous activity at AC synapses can further modulate their own 
synaptic function. 
TRPCs in ACs 
Our experiments with clemizole suggest that TRPC channels are induced to 
admit presynaptic Ca2+ by NO. There is additional evidence in the literature suggesting 
the functional expression of TRPC channels in ACs.  In cultured rat ACs, the broad 
TRPC channel inhibitor SKF96365 reduced GABAergic sPSC frequency, suggesting 
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TRPC channels play a role in synaptic output (Ke et al. 2010).  In our experiments, 
SKF96365 caused an increase in sPSC frequency.   In cultured chick ACs, 2-APB was 
used to inhibit activation of IP3 receptors which prevented both a depolarization- and 
mGluR5-dependent increase in sPSC frequency (Warrier et al. 2005).  Here, (in the 
absence of depolarization or mGluR5 activation) 2-APB caused an increase in sPSC 
frequency.  Having multiple sites of action (DeHaven et al. 2008; Hong et al. 1994; 
Hotta et al. 2005; Leung et al. 1996; Merritt et al. 1990; Prakriya and Lewis 2001; Singh 
et al. 2010; Usmani et al. 2010; Wang 2003), SKF96365 and 2-APB are problematic in 
investigating the involvement of TRPC channels in the NO-dependent increase in 
intracellular Ca2+ and GABAergic sPSC frequency in cultured ACs.  The more specific 
TRPC inhibitor clemizole did not activate spontaneous release on its own, but it was 
effective in suppressing the effects of NO. Clemizole is most selective for TRPC5 (IC50 
= 1.1 μM), however, it can also inhibit TRPC4 (IC50 = 6.4 μM), TRPC3 (IC50 = 9.1 μM), 
TRPC6 (IC50 = 11.3 μM) and TRPC7 (IC50 26.5 μM) (Richter et al. 2014).  Interestingly, 
homomeric TRPC1, TRPC5, or heteromeric TRPC1/5 channels can be activated by S-
nitrosylation (Yoshida et al. 2006). The effects of the S-nitrosylation inhibitor NEM 
alone, however, precluded our use of this reagent to assess the role of this modification.  
Transcripts encoding TRPCs 1, 3-7 have been RT-PCR amplified from pools of 10-20 
cultured ACs (Crousillac et al. 2009).  There is also immunocytochemical evidence that 
TRPC1 is expressed by ACs in the chicken retina and can co-localize with nNOS 
(Crousillac et al. 2003).  The TRPC channel (s) involved in the NO-dependent increase 
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TRPC5 IS REQUIRED FOR THE NO-DEPENDENT INCREASE IN 
DENDRITIC CA2+ AND GABA RELEASE FROM  
RETINAL AMACRINE CELLS 
 
Introduction 
Retinal amacrine cells (ACs) play a major role in processing the visual signal in 
the retina before the signal is sent to the visual cortex of the brain.  There are ~40 
different morphological AC subtypes, and some subtypes of ACs are involved in 
dopamine-dependent light adaptation (Mills and Massey 1995; Xia and Mills 2004), rod 
pathway integration into the cone pathway (Vaney et al. 1991), and direction selectivity 
(Taylor and Smith 2012). The function of majority AC subtypes have not been identified, 
including nitric oxide (NO) producing ACs. Our lab has identified two roles NO plays in 
regulating AC signaling. NO induces Cl- release from internal acidic organelles, which 
can transiently convert typical inhibitory synapses into excitatory (Hoffpauir et al. 2006; 
Krishnan and Gleason 2015), and NO enhances the release of Ca2+ dependent GABA 
release by activating a Ca2+ influx pathway (Maddox and Gleason 2017). 
The enzyme nitric oxide synthase (NOS) synthesizes NO by catalyzing L-
arginine into L-citrulline and NO.  The two Ca2+-sensitive NOS isoforms, endothelial 
NOS (eNOS) and neuronal NOS (nNOS), have been localized to ACs, as well as other 
retinal cell types (Fischer and Stell 1999; Haverkamp et al. 2000; Kim et al. 1999; Pang 
et al. 2010; Tekmen-Clark and Gleason 2013). Neuronal NOS has been specifically 
localized to AC presynaptic terminals in the inner turtle retina (Cao and Eldred 2001), 
and NO stimulates Ca2+ dependent GABA release from ACs, independent of the 
canonical NO receptor soluble guanylate cyclase (Maddox and Gleason 2017; Yu and 
Eldred 2005). In some tissues, NO is traditionally considered a diffusible signaling 
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molecule, however, studies that monitored endogenous NO production in retinas loaded 
with the NO fluorescent indicator DAF-FM have demonstrated that NO is largely 
confined to cellular boundries in turtle (Eldred and Blute 2005), mice (Blom et al. 2012), 
and chicken (Tekmen-Clark and Gleason 2013) retinas, suggesting that NO synthesis 
may affect neurotransmitter release from NO producing cells or from their immediate 
synaptic partners.  
We previously determined that the NO-dependent increase in dendritic Ca2+ and 
GABA release relied on a likely transient receptor potential canonical (TRPC)-mediated 
Ca2+ influx pathway (Maddox and Gleason 2017). Interestingly, it has been shown that 
NO can directly activate TRPC channels via S-nitrosylation (Shimizu et al. 2014; 
Yoshida et al. 2006). S-nitrosylation is a posttranslational modification that can alter the 
function of a protein and occurs when NO binds to a cysteine thiol group. In the mouse 
retina, TRPC1, -4, and -5 are present in the inner plexiform layer (IPL), where ACs form 
synapses, and TRPC3, -6, and -7 is mostly absent (Witkovsky et al. 2008). In the 
mouse IPL, TRPC5 is the most abundant TRPC subunit (Witkovsky et al. 2008).  In the 
chicken retina, TRPC1 expression has been demonstrated in the IPL and TRPC4 is 
expressed by Müller cells (Crousillac et al. 2003). 
 We previously demonstrated that clemizole, an inhibitor for TRPC5, -4, -3, -6, 
and -7 (IC50 = 1.1, 6.4, 9.1, 11.3, and 26.5 µM, respectively) (Richter et al. 2014), 
prevented the NO-dependent dendritic Ca2+ elevation and the increase in GABAergic 
spontaneous postsynaptic current (sPSC) frequency (Maddox and Gleason 2017).  To 
identify the TRPC family member involved in the NO-dependent enhancement of GABA 
release, we employed whole-cell current recordings, Ca2+ imaging, 
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immunocytochemistry, and a CRISPR/Cas9 protein knockdown strategy. In the present 
study, we find that downstream activity of phospholipase C (PLC) is required for the 
NO-dependent increase in sPSC frequency. PLC cleaves phosphatidylinositol-4,5-
bisphosphate (PIP2) into the secondary messengers inositol trisphosphate (IP3) and 
diacylglycerol (DAG). DAG can activate TRPC3, -6, and -7, however, it is thought that 
TRPC4 and -5 are inhibited by PIP2 but can be activated once PLC cleaves PIP2 to 
relieve inhibition (Svobodova and Groschner 2016). We also show that La3+ has a 
biphasic, concentration-dependent effect on sPSC frequency, consistent with TRPC4 
and 5 expression. The TRPC4/C5 inhibitor ML204 had no effect on the NO response at 
10 µM but blocked the NO response at 20 µM. Using the CRISPR/Cas9 system to 
target the 2nd exon of the TRPC5 gene, we find that TRPC5 protein expression is 
required for the NO-dependent Ca2+ influx and GABAergic sPSC frequency increase. 
These findings provide evidence that the NO-dependent activation of TRPC5 can 
enhance GABA release from amacrine cell synapses, which suggests that NO-
dependent TRPC5 activity enhances inhibition in the inner retina. 
Methods 
Plasmid construction 
pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid # 
48138) (Ran et al. 2013). Due to the overlapping excitation/emission wavelengths of 
GFP and the Ca2+ indicator Oregon Green 488 BAPTA-1, AM (OGB, Life Technologies, 
Carlsbad, CA), the GFP gene in pSpCas9(BB)-2A-GFP (PX458) was replaced with 
tdTomato gene from tdTomato-N1 (Addgene plasmid #54642) to create pSpCas9-2A-
tdTomato. tdTomato-N1 was a gift from Michael Davidson and Roger Tsien. The 
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inverted repeat BbsI restriction sites needed to clone the 20-nt guide RNA sequence 
into pSpCas9(BB)-2A-GFP also occurs twice within the tdTomato gene. The BbsI 
restriction sites in pSpCas9(BB)-2A-GFP were replaced with inverted repeat BsaI 
restriction sites prior to replacing GFP with tdTomato. Oligos used to clone the BsaI 
restriction sites into pSpCas9(BB)-2A-GFP were BsaI-F:  
CACCGGAGACCGAGGTCTCC and BsaI-R: AAACGGAGACCTCGGTCTCC. A 20-nt 
guide sequence (AAAAGGGCACTCCGACCAAG) with a quality score of 95 was 
designed using the CRISPR design portal (crispr.mit.edu) to target Cas9 to the 2nd exon 
of TRPC5.  Oligos used to clone the 20 bp TRPC5 guide sequence into pSpCas9-2A-
tdTomato were sgTRPC5-F: caccgAAAAGGGCACTCCGACCAAG and sgTRPC5-R: 
aaacCTTGGTCGGAGTGCCCTTTTc.  The 20 bp guide sequence for TRPC5 was 
cloned into pSpCas9-2A-tdTomato to create pCRISPR-TRPC5. All oligos were 
synthesized by Integrated DNA Technologies (Coralville, IA).   
Amacrine cell cultures and transfections 
The use of chick embryos to prepare retinal cultures was determined to be 
exempt by the LSU Institutional Animal Care and Use Committee. Retinal cell cultures 
were prepared and maintained as previously described (Maddox and Gleason 2017). 
Experiments were performed on ACs that had been in culture for 8-13 days (embryonic 
equivalent days 16 to 21). Over this time in culture, AC-to-AC GABAergic synapses are 
functional.  ACs were identified on morphological criteria (Gleason et al. 1993).  
Dissociated retinas (~8 x 106 cells) from 8-day chick embryos were pelleted and 
resuspended with 100 µL PBS supplemented with 1 mM CaCl, 5 mM glucose, and 
either 5 µg of pSpCas9-tdTomato (–sgRNA) or 5 µg pCRISPR-TRPC5 (+sgRNA).  Cell 
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suspensions were electroporated using Nucleofector II device, program G-013 (Lonza, 
Basel, Switzerland). Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
5% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA) was added to the 
electroporated cell suspension and allowed to rest for 5 min. Transfected cells used for 
current recording/Ca2+ imaging experiments and transfected cells used for 
immunocytochemistry were plated onto tissue culture dishes pretreated with 0.01% 
poly-DL-ornithine hydrobromide (Sigma Aldrich, St. Louis, MO) and coverslips 
pretreated with 0.01% poly-DL-ornithine hydrobromide at a density of ~1 x 106 cells pre-
transfection, respectively. DMEM was replaced 24 hrs after initial plating with 
Neurobasal medium supplemented with 1% serum-free B-27, penicillin (100 U/mL), 
streptomycin (100 µg/mL) and glutamine (2 mM).  
Solutions 
All reagents were purchased from Sigma-Aldrich unless otherwise stated.  
Tetraethylammonium (TEA)-Cl external solution (in mM): NaCl (117), KCl (5.3), TEA-Cl 
(20), CaCl2 (3), MgCl2 (0.41), glucose (5.6), HEPES (10), pH 7.4. High Cl- internal 
solution (in mM): CsCl (110), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl2 (1), 
ATP-2Na+ (3), ATP- 2K+ (1), GTP (2), phosphocreatine (20), creatine phosphokinase 
(50 U/mL), pH 7.4. The high Cl- content of these internal and external solutions sets the 
reversal potential for Cl- at 0 mV and allows spontaneous presynaptic quantal events to 
easily be resolved during current recordings in postsynaptic amacrine cells voltage-
clamped at -70 mV (Borges et al. 1995; Gleason et al. 1993; Maddox and Gleason 
2017). For imaging experiments, the following external solutions were used: Normal 
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external solution (in mM): NaCl (137), KCl (5.37), CaCl2 (3), MgCl2 (0.41), glucose (5.6), 
HEPES (3.02), pH 7.4. 
Reagents  
The NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 500 µM, Enzo, 
Farmingdale, NY) and LaCl3 (2 mM and 10 µM) were dissolved directly into the external 
solution.  4-Methyl-2-(1-piperidinyl)quinolone (ML 204, Tocris Bioscience, Bristol, UK), 
1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U 
73122, Tocris), and 1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-
pyrrolidinedione (U 73343, Tocris) were prepared as 1000 X stocks in DMSO and 
diluted to 1 X into the external solution. The external solution pH was readjusted to 7.4 
after the addition of reagents. 
Electrophysiology 
Whole-cell voltage clamp recordings were performed using Axopatch 1D 
amplifier, Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular 
Devices, Sunnyvale, CA).  Patch pipette electrodes with a tip resistance between 5-10 
MΩ were pulled from thick-walled borosilicate glass (1.5 mm O.D., 0.86 mm I.D.) using 
a P-97 Flaming/Brown Puller (Sutter Instruments, Novato, CA).  A reference Ag/AgCl 
electrode pellet was placed in 3 M KCl and connected to the culture dish with a 3 M KCl 
agarose bridge.  Recordings were performed at room temperature (22-24°C).  A 
pressurized perfusion system (AutoMate Scientific, Berkeley, CA) was used to deliver 
external solutions at a flow rate of 1 mL/min.  Recordings were performed on 
postsynaptic ACs whose processes were in contact with unclamped presynaptic ACs 
and that had spontaneous postsynaptic currents (sPSCs). Transfected cell recordings 
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were performed on postsynaptic tdTomato-expressing cells that were in contact with 
other tdTomato expressing cells. Cells that did not have basal sPSCs also did not 
respond to SNAP and were excluded from the analysis.  
Calcium imaging 
The fluorescent Ca2+ indicator OGB (2 µM) was prepared as previously 
described (Maddox and Gleason 2017). Images were taken every 3 s (200 ms 
exposure). To obtain data relevant to synaptic function, regions of interest (ROIs) were 
chosen at sites of contact between processes.  Images were captured on an inverted 
Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke, Kelheim, 
Germany). ROIs used to obtain data in transfected cell processes expressing tdTomato 
were selected in the tdTomato channel (ex: 554, em: 581) prior to Ca2+ imaging (ex: 
494, em: 523).  Data were collected and analyzed using Slidebook software (Intelligent 
Imaging Innovations, Denver, CO).  In all Ca2+ imaging experiments, the control 
fluorescence mean was calculated by using the average of the last 10 ROI time points 
before switching solutions, and the fluorescence means after switching solutions were 
calculated by using the 10 ROI time points from the middle of each solution application. 
The control and different solution fluorescence means were used to calculate percent 
change in fluorescence. 
Immunocytochemistry 
 Transfected and non-transfected cells on coverslips were fixed using 2% 
paraformaldehyde in PBS for 30 min at 4 °C and then washed 4 X with 30 mM glycine in 
PBS. The last wash contained 0.1% triton X-100 for membrane permeabilization. Fixed 
cells were immediately blocked with 5% normal goat serum in dilution solution (1% 
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BSA/0.5% saponin in PBS) for 30 min at 4 °C. TRPC5 primary monoclonal antibody 
(Sigma-Aldrich, Cat: SAB140977) was diluted in dilution solution (5 µg/mL) and 
incubated for 2 hrs at room temperature. Goat anti-mouse Dylight-488 (Thermo Fisher 
Scientific) secondary antibody was diluted 1:500 in dilution solution and incubated for 1 
hr at room temperature. Coverslips were mounted on plain glass microscope slides 
(Thermo Fisher) using ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher) 
and cured overnight. Labeled cells were viewed on an inverted Olympus IX70 
microscope (Tokyo, Japan), fitted with a SensiCam QE (Cooke, Kelheim, Germany).  
Images were captured and analyzed using Slidebook 5.5 software (Intelligent Imaging 
Innovations, Denver, CO). 
Immunohistochemistry 
 The use of adult chickens to prepare retinal sections and brain protein preps was 
approved by the LSU Institutional Animal Care and Use Committee. Adult white leghorn 
chickens (4-7 weeks old) were sacrificed by intraperitoneal injection of 250 mg/kg 
sodium pentobarbital (Sigma-Aldrich) and decapitated. Eyes were enucleated and 
hemisected. The eye cup was fixed in 4% paraformaldehyde for 1 hr at room 
temperature. The retina was removed and was washed 3 X with PBS containing 1% 
glycine. Retinas were infused with 15% sucrose for 30 min, 20% sucrose for 1 hr, and 
30% sucrose at 4°C overnight. Retinas were placed in 1:1 v/w 30% sucrose and O.C.T. 
compound (Sakura Finetek, Torrence, CA) for 30 min. Retinas in fresh sucrose/OCT 
mixture were frozen in a dry ice/isopentane bath. Retinas were cryosectioned at ~15-18 
µm on a Leica CM1850 cryostat (Wetzlar, Germany) and mounted on Superfrost Plus 
Micro Slides (VWR, Radnor, PA).  
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Sections were washed PBS for 10 min to remove the sucrose/O.C.T. mixture and 
blocked with 5% normal goat serum in dilution solution at 4 °C for 30 min. The primary 
TRPC5 antibody (Sigma-Aldrich) was diluted (5 µg/mL) in dilution solution and 
incubated on blocked sections overnight at 4 °C. Sections were washed 3 X with PBS. 
The goat anti-mouse Dylight-555 secondary antibody (Thermo Fisher) was diluted 1:500 
in dilution solution and incubated in the dark for 1 hr at room temperature. Labeled 
sections were mounted with #1.5 coverslips using ProLong Diamond Antifade mountant 
with DAPI (Thermo Fisher).  Labeled sections were viewed using an inverted Leica TCS 
SP8 Spectral confocal microscope (Leica Microsystems, Wetzlar, Germany) with a 40X 
oil immersion objective (1.25 N.A.). Dylight-555 was observed with white light laser set 
to 562 nm with HyD detector emission collection from 573-600 nm. Images were 
captured using the Leica LAS X software package. Each z-plane was an average of 32 
line scans with 0.3 µm steps.  The brightness of sum intensity projection images of 40 z-
planes were adjusted using ImageJ (NIH).  
Western blot 
Adult chickens were sacrificed as described above. Chicken brains were flash 
frozen with liquid nitrogen and stored at -80°C until use. Brains were homogenized on 
ice in radioimmunoprecipitation assay buffer (150 mM NaCl, 1% Triton X-100, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris, pH 8.0) containing 
phosphatase inhibitor cocktail 2 (Sigma-Aldrich) and protease inhibitor cocktail (Sigma-
Aldrich). Homogenates were centrifuged at 17,000 x g for 20 min at 4°C. The 
supernatant was immediately aliquoted and stored at -80°C. Protein concentration was 
determined using the BCA Protein Assay Kit from Pierce (Rockford, IL). Prior to 
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electrophoresis, protein samples were prepared in Laemmli buffer containing 2% SDS, 
5% 2-metcaptoethanol, 10% glycerol, 0.005% bromophenol blue, and 62.5 mM Tris. 
Protein samples (20 µg) in Laemmli buffer were incubated at 60 °C for 30 min. Proteins 
were separated on an 8% bis-acrylimide/SDS gel with 10 µL of Precision Plus Protein 
Dual Color Standard (BioRad, Hercules, CA). Separated proteins were transferred onto 
nitrocellulose membrane at 4 °C overnight.  The membrane was blocked with 1X 
blocking buffer (Abcam, Cambridge, MA) in Tris-buffered saline with 0.1% Tween 20 
(TBS-T) for 1 hr at room temperature. The blocking buffer was replaced with the diluted 
primary anti-TRPC5 antibody (1:1000) in 1X blocking buffer/TBS-T and incubated 
overnight at 4 °C. The membrane was washed 3 X with TBS-T. The goat anti-mouse 
secondary antibody conjugated with horseradish peroxidase (BioRad) was diluted 
1:5,000 in 1X blocking buffer/TBS-T. The membrane was incubated with the secondary 
antibody for 1 hr. The membrane was washed three times with TBS-T. Protein was 
visualized using the Clarity chemiluminescence kit (BioRad) and the ChemiDoc XRS+ 
system (BioRad). Western blot images were captured using the Image Lab Software 
(BioRad).  
TRPC5 gene mutation analysis  
To detect indels (insertions/deletions) in the 2nd exon of TRPC5 by non-
homologous end joining induced by Cas9-mediated dsDNA cleavage, genomic DNA 
(gDNA) from whole dishes containing transfected and non-transfected cells was isolated 
using Arcturus PicoPure kit (Thermo Fisher).  The 2nd exon of TRPC5 was PCR 
amplified using Q5 Hotstart High Fidelity DNA polymerase (New England Biolabs, 
Ipswich, MA) and primers that were designed to anneal within the introns flanking the 
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2nd exon (gDNA-TRPC5-F: GGGGTTAGTCGTGGAGCATT; gDNA-TRPC5-R: 
GTACCACATTTGCTCTGGGC). Correct PCR amplification was verified by sequencing 
(Eurofins Genomics, Louisville, KY).  Purified gDNA PCR products (~721 bp) from 
pCRISPR-TRPC5 transfections and pSpCas9-tdTomato transfections were used in the 
T7 Endonuclease I (T7E1) mutation detection assay (NEB), which recognizes and 
cleaves mismatched dsDNA. PCR products (200 ng) from each gDNA amplification 
(pCRISPR-TRPC5 transfections and pSpCas9-2A-tdTomato) were denatured and 
slowly reannealed to allow heteroduplex formation. Each heteroduplexed DNA sample 
was digested with T7E1 (10 U) for 30 min at 37 °C.  DNA (50 ng) from each T7E1 
digestion was separated by 2% agarose gel electrophoresis, stained with ethidium 
bromide, and visualized using the ChemiDoc XRS+ system (BioRad). Images were 
captured and analyzed using the Image Lab Software (BioRad).  
Data analysis 
For sPSC electrophysiology experiments, Mini Analysis Program (Synaptosoft, 
Inc, Fort Lee, NJ) was used to detect and analyze sPSCs.  For immunocytochemistry 
experiments on transfected cells, slidebook software (Intelligent Imaging Innovations) 
was used to create a threshold mask in the TRPC5 channel based on non-transfected 
cells labeled with only the secondary antibody. The threshold mask for TRPC5 was 
applied to images of cells transfected with pSpCas9-tdTomato (Control) and pCRISPR-
TRPC5 (TRPC5 KD). Due to their thickness, cell bodies were removed from the TRPC5 
mask in all images, and only processes with tdTomato expression were used for 
analysis.  Slidebook software automatically calculated TRPC5 mask descriptive 
statistics for TRPC5 objects > 5 pixels for total TRPC5 object area, TRPC object size, 
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TRPC5 object intensity, and tdTomato intensity in TRPC5 object area. Welch’s t-tests 
were performed on TRPC5 mask descriptive statistics. Repeated Measures-ANOVA 
with Fisher’s Least Significant Difference (LSD) post hoc analysis was performed on all 
Ca2+ imaging and electrophysiology data unless otherwise indicated.  Statistics were 
performed using GraphPad Prisim 7 (GraphPad Software, La Jolla, CA).  Data are 
reported as mean ± SE.  
Results 
PLC activity is required for the NO-dependent GABA release from retinal ACs 
 We previously demonstrated that nitric oxide (NO) enhances spontaneous and 
evoked Ca2+-dependent GABA release by activating a transient receptor potential 
canonical (TRPC) channel-mediated Ca2+ influx pathway, without the requirement of 
Ca2+ stores, action potentials, or activation of the NO receptor sGC (Maddox and 
Gleason 2017). All TRPC family members (1-7) are known to be activated, albeit by 
different mechanisms, by downstream phospholipase C (PLC) activity (Svobodova and 
Groschner 2016).  To determine if PLC activity is required for the NO-dependent 
increase in spontaneous postsynaptic current (sPSC) frequency, the effects of the 
broad PLC inhibitor U73122 (10 µM) was tested.  The NO donor SNAP (500 µM) 
caused a significant increase in sPSC frequency by 68.3% (control, 24.9 ± 8.4/30 s, 
SNAP, 41.9 ± 10.3/30 s, P = 0.0012, n = 8, Figure 3.1A,B). Application of the PLC 
inhibitor U73122 together with SNAP significantly reduced the NO-dependent increase 
in sPSC frequency by 74.1% (SNAP, 41.9 ± 10.3/30 s, SNAP/U 73122, 10.89 ± 2.5/30 
s, P = 0.017, n = 8, Figure 3.1A,B). U73343 (the less active analog of U73122) did not 
influence the NO-dependent increase in sPSC frequency (SNAP, 38.6 ± 9.8/30 s, 
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SNAP/U 73343, 37.8 ± 6.0/30 s, P = 0.85, n = 8, Figure 3.1C,D).  Additionally, 
application of U73122 alone significantly reduced basal sPSC frequency by 61.5% 
(control, 15.81 ± 3.3/30 s, U73122, 6.09 ± 0.92/30 s, P = 0.0096, n = 10, paired t-test, 
Figure 3.1E,F). U73343, however, did not alter basal sPSC frequency (control, 38.7 ± 
12.04/30 s, U73343, 28.96 ± 6.9/30 s, P = 0.23, n = 6, paired t-test, Figure 3.1E,F). 
These results suggest PLC activity is required for basal spontaneous GABA release. 
Although TRPC channels can be activated independent of PLC activity, the NO-
dependent increase in spontaneous GABA release cannot overcome the requirement of 
PLC activity. 
The NO-dependent increase in sPSC frequency is sensitive to La3+ 
 We have previous shown that the NO-dependent increase in cytosolic Ca2+ and 
sPSC frequency is blocked by clemizole, a TRPC channel inhibitor with highest affinity 
for TRPC5 and TRPC4, respectively (Maddox and Gleason 2017). Additionally, we now 
show that downstream PLC activity is required for the NO-dependent increase in sPSC 
frequency.  Together, these findings argue for the involvement of a TRPC channel, 
possibly TRPC4 or TRPC5.  Unique to TRPC4 and TRPC5, mM concentrations of 
lanthanides block these channels currents and µM concentrations potentiate channel 
activity (Jung et al. 2003). To test whether TRPC4 or TRPC5 are involved, the effects of 
La3+ were evaluated.  In 2 mM La3+, SNAP was unable to increase sPSC frequency (2 
mM La3+, 5.4 ± 1.9/30 s, 2 mM La3+/SNAP, 4.8 ± 1.4/30 s, P = 0.52, n = 8, Figure 
3.2A,B). When 2 mM La3+ was removed, SNAP caused a significant increase in sPSC 
frequency by 639% (SNAP/La3+, 4.8 ± 1.4/30 s, SNAP, 35.3 ± 13.4/30 s, P = 0.04, n = 
8, Figure 3.2A,B). Conversely, after NO caused a significant increase in sPSC  
	 63 
frequency (control, 20.08 ± 4.97/30 s, SNAP, 32.23 ± 6.26/30 s, P = 0.025, n = 9, Figure 
3.2C,D), 10 µM La3+ enhanced the NO-dependent increase in sPSC frequency by 
77.5% (SNAP, 32.23 ± 6.26/30 s, SNAP/10 µM La3+, 57.23 ± 12.96/30 s, P = 0.018, n = 
9, Figure 3.2C,D). This differential effect of La3+ on sPSC frequency suggests that the 
















Figure 3.1. PLC activity is required for the NO-dependent increase in sPSC frequency. A: 
representative recording from a postsynaptic AC voltage clamped at -70 mV. The PLC 
inhibitor U73122 (10 µM) reduced the NO-dependent increase in sPSC frequency. B: 
quantified mean event frequency/30 s ± SE; n = 10. *P < 0.05, **P <0.01. C: 
representative recording from a postsynaptic AC voltage clamped at -70 mV.  The less 
active U73343 (10 µM) did not affect the NO-dependent increase in sPSC frequency. D: 
quantified mean event frequency/30 s ± SE; n = 6. *P < 0.05, **P <0.01. E,F: 
representative recordings from postsynaptic ACs voltage clamped at -70 mV. Perfusion 
of only U73122 reduced sPSCs frequency (E). Perfusion of only U73343 had no effect on 
sPSC frequency (F). G,H: quantified mean event frequency/30 s ± SE; n = 10 (G), n = 6 













Figure 3.2. The NO-dependent increase in sPSC frequency is sensitive to La3+.  A: 
representative recording from postsynaptic AC voltage clamped at -70 mV. 2 mM La3+ 
prevented the NO-dependent increase in sPSC frequency when exposed to the NO donor 
SNAP. When 2 mM La3+ was removed and SNAP remained, NO increased the sPSC 
frequency. B: quantified mean event frequency/30 s ± SE; n = 8. *P < 0.05. C: 
representative recordings from postsynaptic ACs voltage clamped at -70 mV. 10 µM La3+ 
enhanced the NO-dependent increase in sPSC frequency. D: quantified mean event 
frequency/30 s ± SE; n = 9. *P < 0.05, **P < 0.01. 
 
ML204 can block the NO-dependent increase in cytosolic Ca2+ 
 ML204 preferentially inhibits TRPC4 channels with an IC50 of 1 µM in Ca2+ 
imaging and 3 µM in whole-cell current recordings (Miller et al. 2011). In over 
expression cell lines, 10 µM ML204 nearly inhibits TRPC4 currents completely and 
inhibits TRPC5 currents by ~ 68 % (Miller et al. 2011), suggesting that higher 
concentrations of ML204 are needed to sufficiently block TRPC5. To determine if 10 µM 
ML204 can block the NO-dependent increase in cytosolic Ca2+, changes in cytosolic 
Ca2+ in regions of process contacts (potential synaptic sites) were monitored using the 
fluorescent Ca2+ indicator Oregon Green BAPTA-488 that was preloaded into ACs. 
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ML204 alone had no effect on cytosolic Ca2+ (control, 8.19 ± 0.59 A.U., 10 µM ML204, 
8.09 ± 0.58 A.U., P = 0.093, n = 53, Figure 3.3A,B). While 10 µM ML204 was still 
present, the NO donor SNAP caused a significant increase in cytosolic Ca2+ by 6.2 % 
(10 µM ML204, 8.09 ± 0.58 A.U., 10 µM ML204/SNAP, 8.6 ± 0.56 A.U., P = 0.001, n = 
53, Figure 3.3A,B). Cytosolic Ca2+ remained elevated when 10 µM ML204 was removed 
and only SNAP remained (10 µM ML204/SNAP, 8.6 ± 0.56 A.U., SNAP, 8.78 ± 0.61 
A.U., P = 0.46, n = 53, Figure 3.3A,B). Also, 10 µM ML204 did not block the NO-
dependent increase in sPSC frequency (10 µM ML204, 13.06 ± 2.5/30 s, 10 µM 
ML204/SNAP, 21.78 ± 3.7/30 s, P = 0.027, n = 9, Figure 3.3C,D). sPSC frequency 
remained elevated when 10 µM ML204 was removed and only SNAP remained (10 µM 
ML204/SNAP, 21.78 ± 3.7/30 s, SNAP, 40.08 ± 18.9/30 s, P = 0.3, n = 9, Figure 
3.3C,D). To further test the effectiveness of ML204 on the NO response, the 
concentration of ML204 was increased to 20 µM. Co-application of 20 µM ML204 and 
SNAP blocked the NO-dependent increase in cytosolic Ca2+ (20 µM ML204, 6.6 ± 0.3 
A.U., 20 µM/SNAP, 6.51 ± 0.3 A.U., P = 0.15, n = 102, Figure 3.3E,F) and the NO-
dependent increase in sPSC frequency (20 µM ML204, 20.38 ± 4.8/30 s, 20 µM 
ML204/SNAP, 23.78 ± 5.5/30 s, P = 0.48, n = 12, Figure 3.3G,H). When 20 µM ML204 
was removed and only SNAP remained, NO caused a significant increase in cytosolic 
Ca2+ by 5.3% (20 µM ML204/SNAP, 6.51 ± 0.3 A.U., SNAP, 6.85 ± 0.32 A.U., P < 
0.0001, n = 102, Figure 3.3E,F) and in sPSC frequency by 70% (20 µM ML204/SNAP, 
23.78 ± 5.5/30 s, SNAP, 35.35 ± 6.7/30 s, P = 0.02, n = 12, Figure 3.3G,H). The ability 
for ML204 to block the NO-dependent response at 20 µM but not 10 µM suggests that 
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NO is acting on TRPC5, not TRPC4, to activate the NO-dependent Ca2+ influx pathway 













Figure 3.3.  The TRPC4/C5 inhibitor ML204 can block the NO-dependent increase in 
cytosolic Ca2+ and sPSC frequency at higher concentrations.  A: co-application of 10 µM 
ML204 and NO donor SNAP did not prevent the NO-dependent increase in cytosolic Ca2+. 
Cytosolic Ca2+ remained elevated upon removal of 10 µM ML204 from the bath.  B: 
quantified mean fluorescence ± SE; n = 53. C: current recording from a representative 
amacrine cell voltage clamped at -70 mV.  10 µM ML204 was not effective at blocking the 
NO-dependent increase in sPSC frequency. D: quantified mean event frequency/30 s ± 
SE; n = 13. E: 20 µM ML204 blocked the NO-dependent increase in cytosolic Ca2+.  NO 
increased cytosolic Ca2+ after removing 20 µM ML204 from the bath and SNAP remained. 
F: quantified mean fluorescence ± SE; n = 102. G: current recording from a representative 
amacrine cell voltage clamped at -70 mV.  20 µM ML204 blocked the NO-dependent 
increase in sPSC frequency. NO increased sPSC frequency upon removal of 20 µM 
ML204 from the bath and SNAP remained. H: quantified mean event frequency/30 s ± 
SE; n = 12. *P < 0.05, **P < 0.01, ***P < 0.001. ***P < 0.0001, ns, not significant. 
Fluorescence over time data are plotted as mean fluorescence ± SE.  
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TRPC5 is expressed in ACs in culture and retina 
 Inhibitors for the TRPC channels are not completely specific for a single TRPC 
family member, however, previous experiments using clemizole, which preferentially 
inhibits TRPC5 (Maddox and Gleason 2017), blocked NO-dependent dendritic Ca2+ 
elevations and the increase in sPSC frequency.  Here, 10 µM ML204 did not block the 
NO response, however, 20 µM ML204 blocked the NO-dependent increase in cytosolic 
Ca2+ and the increase in sPSC frequency (Figure 3.3). The results using these two 
inhibitors suggests that NO may be activating TRPC5, not TRPC4, to admit Ca2+ into 
the presynaptic terminal and enhance vesicular GABA release. To determine if ACs in 
culture and the adult retina express TRPC5, we used a monoclonal TRPC5 antibody 
raised against amino acids 534 – 603 of the human TRPC5 protein (96% antigen 
homology with the chicken TRPC5). This antibody recognizes a single band in a 
western blot around the appropriate molecular weight of TRPC5 (112 kDa) in chicken 
brain homogenate (Figure 3.4A).  The TRPC5 antibody recognizes cell bodies and 
processes in cultured ACs (Figure 3.4B) and AC bodies (arrowheads, Figure 3.4C) and 
processes arising from AC bodies into the IPL (arrowheads, Figure 3.4D) in the retina. 
Additionally, there was TRPC5 labeling in Müller cell bodies in the INL (arrows, Figure 
3.4C) and in cell bodies in the GCL (asterisks, Figure 3.4C). The punctate TRPC5 
labeling pattern in the IPL, where ACs form synapses, suggests that TRPC5 forms 
clusters in the IPL, possibly at AC presynaptic terminals.  
CRISPR/Cas9-mediated dsDNA break of the TRPC5 gene reduces TRPC5 expression  
 To confirm that TRPC5 is the Ca2+ permeable channel involved in the NO 













Figure 3.4.  Amacrine cells in culture and adult retina express TRPC5. A: Western blot 
for TRPC5 in chicken brain protein with the monoclonal TRPC5 (1C8 clone) antibody 
recognizes a single band at the appropriate molecular weight (112 kDa). B: an amacrine 
cell in culture immunolabeled with the TRPC5 antibody and DNA marker DAPI. C: adult 
chicken retina immunolabeled with the TRPC5 antibody.  Likely Müller cell bodies 
(arrows) and amacrine cell bodies (arrow heads) within the INL are clearly labeled. Cell 
bodies in the GCL are also labeled (asterisks). Strong punctate labeling is present in the 
IPL, suggesting that TRPC5 clusters within processes D: expanded view of the box in C. 
TRPC5 is present within a process arising from an amacrine cell body (arrow heads). PR, 
photoreceptors; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer.  
 
dsDNA breaks in the 2nd exon of the TRPC5 gene (Ran et al. 2013).  After dsDNA 
breaks, the cellular DNA repair machinery will generate insertions/deletions (indels) at 
the site of the dsDNA break, which will lead to reduced expression or expression of non-
functional protein. To confirm that a Cas9-mediated dsDNA break within the 2nd exon of 
TRPC5 promoted indels, we employed the T7 endonuclease I (T7E1) mutation 
detection assay (NEB). Heteroduplexed PCR products of the TRPC5 2nd exon from 
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cultures transfected with the control plasmid pSpCas9-tdTomato were not digested by 
T7E1, therefore, no indels were present (Figure 3.5A, left lane, control). Cultures 
transfected with pCRISPR-TRPC5 contained indels because heteroduplexed PCR 
products were digested by T7E1 into the predicted sizes based on the Cas9-targeted 
cut site (Figure 3.5A, right lane, TRPC5 KD). 
 To confirm CRISPR/Cas9-mediated TRPC5 dsDNA breaks lead to reduced 
expression of TRPC5, ACs that were transfected with either pSpCas9-tdTomato 
(control, Figure 3.5B-D & Bi-Di) or pCRISPR-TRPC5 (TRPC5 KD, Figure 3.5E-G & Ei-
Gi) were immunolabeled using the same TRPC5 antibody in Figure 3.4. CRISPR/Cas9-
mediated dsDNA breaks in the TRPC5 gene reduced total dendritic TRPC5 labeled 
area (control, 9.67 ± 1.0 µm2, n = 30, TRPC5 KD, 1.95 ± 0.2 µm2, n = 43, P < 0.0001, 
Welch’s t-test, Figure 3.5H), TRPC5 object size (control, 125.4 ± 12.41 nm2, n = 30, 
TRPC5 KD, 76.36 ± 3.66 nm2, n = 43, P = 0.0006, Welch’s t-test, Figure 3.5I), and 
TRPC5 object intensity (control, 15019 ± 1419 A.U., n = 30, TRPC5 KD, 11454 ± 789.4 
A.U., n = 43, P = 0.03, Welch’s t-test, Figure 3.5J).  There was no significant difference 
in tdTomato fluorescence within the TRPC5 object domain (control, 120103 ± 12018 
A.U., n = 30, TRPC5 KD, 101802 ± 7154 A.U., n = 43, P = 0.2, Welch’s t-test, Figure 
5K). 
TRPC5 is required for the NO-dependent increase in cytosolic Ca2+ and GABA release 
 The CRISPR/Cas9-mediated knockdown of TRPC5 was used to investigate the 
role of TRPC5 in the NO-dependent Ca2+ influx and enhancement of GABA release. In 
ACs transfected with the control plasmid pSpCas9-tdTomato, NO caused a 3% increase 

















Figure 3.5.  CRISPR/Cas9-mediated TRPC5 mutagenesis reduces TRPC5 expression in 
amacrine cell processes. A: T7 endonuclease I (T7EI) indels (insertions/deletions) 
detection assay. The 2nd TRPC5 exon genomic DNA region from cultures transfected with 
either pSpCas9-tdTomato (Control) or pCRISPR-TRPC5 (TRPC5 KD) was PCR 
amplified, denatured, and slowly reannealed to form mismatched heteroduplex DNA 
(hdDNA). hdDNA was then digested with T7EI, which recognizes mismatched 
nucleotides. T7EI only recognized and digested hdDNA mismatched nucleotides from 
TRPC5 KD into predicted sizes (408 bp and 313 bp). B-G, amacrine cells transfected 
with pSpCas9-tdTomato (Control, B-D) or pCRISPR-TRPC5 (TRPC5 KD, E-G) and 
immunolabeled for TRPC5. Scale bars, 10 µm. Insets in B-G correspond to Bi-Gi, 
respectively. Scale bars, 5 µm.  H-K, quantification of TRPC5 labeling in processes from 
pSpCas9-tdTomato (control) and pCRISPR-TRPC5 (TRPC5 KD) transfected cells. 
TRPC5 KD significantly reduced the total area of TRPC5 immunofluorescence (H), 
TRPC5 object size (> 5 pixels, I), intensity (int.) of TRPC5 object (> 5 pixels) 
immunofluorescence (J), and TRPC5 immunofluorescence intensity that falls within 
tdTomato fluorescence (K). Mean (dotted line) ± SE.  All data points are plotted. Control 
(light grey circles), n = 30. TRPC5 KD (dark grey circles), n = 43. *P < 0.05, ***P < 0.001 
****P < 0.0001 (Welch’s t-test). 
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Figure 3.6A-B) and a 47.5% increase in sPSC frequency (control, 16.5 ± 4.2/30 s, 
SNAP, 24.3 ± 4.7/30 s, n = 9, P = 0.009, Figure 3.6C-D). In ACs transfected with 
pCRISPR-TRPC5, NO did not increase cytosolic Ca2+ (control, 4.53 ± 0.23 A.U., SNAP, 
4.44 ± 0.23 A.U., n = 255, P < 0.0001, Figure 3.6E-F) and did not increase sPSC 
frequency (control, 19.84 ± 4.99/30 s, SNAP, 20.11 ± 5.55/30 s, n = 9, P = 0.78, Figure 
3.6G-H).  These data confirm that TRPC5 is required for the NO-dependent influx of 
Ca2+ into the presynaptic terminal and enhanced Ca2+-dependent vesicular GABA 
release.  
Discussion 
 To our knowledge, this is the first report demonstrating that a member of the 
canonical TRP family, TRPC5, mediates NO-dependent vesicular neurotransmitter 
release at a GABAergic synapse. Here, we find the action of NO on sPSC frequency is 
dependent on downstream activity of PLC, is blocked with 2 mM La3+, and is enhanced 
by 10 µM La3+. The requirement of PLC activity and dual effects of La3+ are 
characteristic of TRPC4 and TRPC5 channels. The TRPC4/C5 inhibitor ML204 at 10 
µM did not block the NO response, however 20 µM ML204 prevented the NO-
dependent increase in dendritic Ca2+ and sPSC frequency. CRISPR/Cas9-mediated 
genetic knockdown of TRPC5 using a guide RNA designed to target Cas9 to the 2nd 
exon of TRPC5 precluded an NO-dependent increase in dendritic Ca2+ and sPSC 
frequency. Additional evidence that further supports TRPC4 is not involved in the NO-
response is provided by previous work in the Gleason lab that demonstrated TRPC4 is 
not expressed by ACs in culture or by ACs in adult retina (Crousillac et al. 2003). These 












Figure 3.6. Knockdown of TRPC5 eliminates the NO-dependent increase in cytosolic Ca2+ 
and sPSC frequency. A-D, data from amacrine cells transfected with pSpCas9-tdTomato 
(Control). A, The NO-dependent increase in cytosolic Ca2+ in amacrine cell processes 
was still present in control cells. B, quantified mean fluorescence ± SE, n = 149. ****P < 
0.0001. C, recording from a representative amacrine cell voltage clamped at -70 mV and 
in contact with other transfected amacrine cells. SNAP still caused an increase in sPSC 
frequency in cells transfected pSpCas9-tdTomato. D, quantified mean event 
frequency/30 s ± SE; n = 9. **P < 0.01, paired t-test. E-F, data from amacrine cells 
transfected with pCRISPR-TRPC5 (TRPC5 KD). E, The NO-dependent increase in 
cytosolic Ca2+ was absent in amacrine cells transfected with pCRISPR-TRPC5. F, 
quantified mean fluorescence ± SE; n = 255. G, recording from a representative amacrine 
cell transfected with the pCRISPR-TRPC5. Cells were voltage clamped at -70 mV and 
were in contact with other transfected amacrine cells. SNAP was unable to cause an 
increase in sPSC frequency in cells transfected with pCRISPR-TRPC5. H, quantified 
mean event frequency/30 s ± SE; n = 9. P = 0.78 (paired t-test). 
 
release at retinal AC GABAergic synapses via a TRPC5-mediated Ca2+ influx into the 
presynaptic terminal. 
TRPC5 in the retina and brain 
 First identified in a Drosophila melanogaster mutant screen for visual defects 
(Cosens and Manning 1969), the transient receptor potential (TRP) channel was named 
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due to the shortened response of photoreceptors under intense illumination (Minke 
2010; Minke et al. 1975). Almost all members of the TRP channel superfamily are 
expressed with varying degree in the vertebrate retina, however, the role of TRP 
channels in visual signal processing in the vertebrate retina remains to be fully explored. 
Recent work has identified a vertebrate TRP channel of the melastatin subfamily, 
TRPM1, necessary for depolarizing light responses of retinal ON-bipolar cells (Koike et 
al. 2010; Morgans et al. 2009). Additionally, patients that suffer from complete 
congenital stationary night blindness have a TRPM1 gene mutation (Audo et al. 2009; 
Nakamura et al. 2010). Here, we identified a TRP channel in the canonical subfamily, 
TRPC5, that may be involved in processing the visual signal by enhancing GABAergic 
inhibition in the inner retina.  
In the brain, studies have identified that TRPC5 has an essential role in dendritic 
length, patterning, and growth cone morphology in developing hippocampal neurons 
(Greka et al. 2003; He et al. 2012; Puram et al. 2011). One study found that binding of 
epidermal growth factor leads to a rapid insertion of readily available vesicles containing 
TRPC5, and this pathway is needed for proper hippocampal neuron development 
(Bezzerides et al. 2004). The role of TRPC5 in mature neurons is not fully understood. 
Two studies, however, have identified separate roles for TRPC5 in mature neurons in 
the brain including innate fear processing in the amygdala (Riccio et al. 2009) and 
seizures and seizure-induced cell death in the hippocampus (Phelan et al. 2013). To 
date, there are no published studies investigating the physiological role of TRPC5 in the 
retina. 
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In the mouse retina, TRPC5 expression is inner row of the inner nuclear layer 
(INL) where AC bodies lie (Gilliam and Wensel 2011). However, a separate study 
characterizing dopaminergic interplexiform processes in the mouse retina found TRPC5 
immunolabeling to be mostly restricted to the synaptic layers, inner plexiform layer (IPL) 
and outer plexiform layer (OPL) (Witkovsky et al. 2008). The TRPC5 labeling pattern 
presented here is comparable to the mouse retina and was found to be in cell bodies 
within the inner half of the INL (likely Müller cells and ACs) and cell bodies in the 
ganglion cell layer. Additionally, there was extensive punctate labeling within the IPL. 
The punctate labeling within the IPL suggests that TRPC5 might form clusters at 
possible synaptic sites, however, synaptic localization of TRPC5 within the retina 
remains unknown.  
Identification of NO-dependent activation of TRPC5 
 PLC downstream activity is known to be an activator of all TRPC channels, 
however, the PLC activity-dependent activation of each TRPC family member is not fully 
understood. Two studies have demonstrated that TRPC4 (Otsuguro et al. 2008) and 
TRPC5 (Obukhov and Nowycky 2004; Trebak et al. 2009) are inhibited by 
phosphatidylinositol 4,5-bisphosphate (PIP2) and become activated once PLC relieves 
this inhibition by cleaving PIP2 into inositol trisphosphate (IP3) and diacylglycerol (DAG). 
A previous study using the global PLC inhibitor U73122 and the disulfide agent 2,2’-
dithiobis(5-nitropyridine) demonstrated in an over expression system that direct 
activation of TRPC5 via cysteine thiol modification did not require PLC activity (Yoshida 
et al. 2006). The results presented here suggest that that PLC activity is require for the 
NO-dependent activation of TRPC5 and increase in sPSCs. U73122, however, also 
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abolished almost all baseline sPSCs. This suggests S-nitrosylation-dependent 
activation of natively expressed TRPC5 in ACs may not overcome the PLC-dependence 
of spontaneous GABA release. Of the two known mechanisms in which NO functions 
(the NO-sGC pathway and S-nitrosylation), we previously established that the NO-sGC 
pathway is not involved in the NO response. Although the exact mechanism in which 
NO activates TRPC5 to enhance vesicular GABA release remains unknown, TRPC5 
may have a physiological role in the inner retina to enhance inhibition.  
Effects of NO on amacrine cells 
NO has previously been shown to enhance the release of GABA in all layers of 
the turtle retina (Yu and Eldred 2005), however, this was indirectly demonstrated by the 
NO-dependent reduction in labeling of a preloaded GABA analog, g-vinyl-GABA (GVG) 
(Yu and Eldred 2005). Interestingly, the NO-dependent reduced GVG labeling was 
largely dependent on extracellular Ca2+ in the IPL, which is where processes from 
amacrine cells ramify and form synapses (Yu and Eldred 2005).  Another study found 
that NOS-stimulated NO production with its substrate L-arginine dampens both ON and 
OFF light responses in all major ganglion cell types, with the OFF response being the 
most sensitive to NO (Wang et al. 2003). Since NO only affected the intrinsic ganglion 
cell membrane properties of a small population of each ganglion cell type, it was 
suggested that NO works at a site immediately presynaptic to ganglion cells (likely 
amacrine cells) to increase inhibition and dampen the light responses (Wang et al. 
2003). Incorporating the findings of these two studies with the findings in my 
dissertation, NO may have reduced ganglion cell light responses (Wang et al. 2003) by 
	 76 
increasing Ca2+-dependent GABA release (Yu and Eldred 2005) through the NO-
dependent TRPC5-mediated Ca2+ influx into amacrine cells.  
Multiple effects of NO on amacrine cell synapses 
We previously demonstrated that NO activates a Ca2+ influx pathway that is 
sufficient to drive vesicular exocytosis and GABA release without depolarization 
(Maddox and Gleason 2017). Here, using the TRPC4/C5 inhibitor ML204 and 
CRISPR/Cas9-mediated knockdown of gene expression, we identify the channel 
responsible for the NO-dependent Ca2+ influx as TRPC5. Previous work in the Gleason 
lab determined that higher concentrations of NO (~2 µM) transiently alter inhibitory 
postsynaptic voltage responses in ACs by releasing Cl- from internal acidic 
compartments (Hoffpauir et al. 2006; Krishnan and Gleason 2015). This Cl- release 
shifts the reversal potential of GABA-gated currents more positive and changes 
postsynaptic voltage responses to less inhibitory or even excitatory. Taken together, 
these results suggest that locally generated NO in the inner retina can affect both pre- 
and postsynaptic sites:  voltage-independent GABA release is enhanced and GABA 
action on the postsynaptic amacrine cell can lead to depolarization.  If these actions co-
occur, then they will enhance inhibitory output from the downstream AC (See Figure 
3.7).  The patterns of NO production under different stimulus conditions will determine 
the sites of enhanced GABAergic output and thus the impact on the signals that 


















Figure 3.7. NO has pre- and postsynaptic effects in ACs.  A: Simplified cartoon of a 
GABAergic AC (light grey) in the retina receiving glutamatergic input from a bipolar cell 
(BC) and presynaptic to another AC (Left).  NO synthesis in a NOS expressing AC (red) 
can elicit changes in both pre- and postsynaptic processes (Right).  B: Expanded view of 
the box in A, depicting presynaptic and postsynaptic effects of NO.  Top, Activation of a 
Ca2+-dependent isoform of NOS (eNOS or nNOS) produces NO (1.).  NO activates 
TRPC5, possibly via S-nitrosylation (S-NO?), to admit Ca2+ into the presynaptic terminal 
(2.).  Ca2+ elevations in the presynaptic terminal lead to increased vesicle fusion events 
and GABA release (3.) onto its postsynaptic partner.  VGCC, voltage-gated Ca2+ channel; 
GluR, ionotropic glutamate receptor.  Bottom, NO diffuses into the postsynaptic terminal 
and induces Cl- release from acidic organelles (4., Krishnan and Gleason, 2015).  
Increased [Cl-] in the postsynaptic terminal reverses the Cl- gradient, converting typical 
GABAergic inhibition into depolarization (5., Hoffpauir et al. 2006).  Depolarization (+) 
leads to activation of VGCCs in an adjacent presynaptic site in the same process (6.).  
Ca2+ influx through activated VGCCs leads to enhanced GABA release (7.).  The 
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In Chapter 2, I provide direct evidence that NO enhances neurotransmitter 
release at retinal AC GABAergic synapses, independent of the canonical NO receptor, 
sGC, and presynaptic action potentials.  Ca2+ imaging at regions of process contacts 
and whole-cell current recordings of spontaneous and evoked GABA release revealed 
that NO activates a Ca2+ influx pathway, independent of Ca2+ release from stores. The 
TRPC inhibitor clemizole, which preferentially blocks TRPC5, blocked the NO-
dependent Ca2+ elevation and the increase in sPSC frequency.  Since NO is 
endogenously produced in vertebrate retinas (Blom et al. 2012; Eldred and Blute 2005; 
Tekmen-Clark and Gleason 2013), these findings suggest that NO enhances inhibition 
by activating a TRPC-mediated Ca2+ influx and enhancing Ca2+-dependent vesicular 
GABA release from ACs. 
 In Chapter 3, I determined that the Ca2+ permeable, nonselective cation channel 
TRPC5 mediates the NO-dependent Ca2+ influx and increase in GABA release. The first 
pieces of evidence that suggested the involvement TRPC5 was that downstream PLC 
activity is required and that 2 mM La3+ blocks and 10 µM La3+ enhances the NO-
dependent response. The requirement of PLC activity and the dual effects of La3+ on 
the NO response are unique characteristics of TRPC4 and TRPC5 channel activity. 
ML204, another TRPC inhibitor that preferentially blocks TRPC4, had no effects on the 
NO-dependent Ca2+ elevations or increase in sPSC frequency, suggesting the 
involvement of TRPC5 and not TRPC4. Previous work in the Gleason lab demonstrated 
that TRPC4 is not expressed by ACs in culture or in the adult retina, further suggesting 
that TRPC4 is not involved.  Immunolabeling experiments in my dissertation revealed 
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that TRPC5 is expressed by ACs both in culture and in the adult retina. Using the 
CRISPR/Cas9 system, genetic knockdown of protein expression allowed me to correctly 
identify the involvement of TRPC5 in the NO response. Reduced TRPC5 expression in 
transfected ACs precluded the NO-dependent Ca2+ elevation and the NO-dependent 
increase in sPSC frequency. Since ACs in the retina can produce NO and express 
TRPC5, these findings suggest that NO enhances GABAergic inhibition in the inner 
retina by activating TRPC5.  
TRPC5 has been shown to be directly activated by S-nitrosylation (Yoshida et al. 
2006). In my experiments, the mechanism in which NO activates TRPC5 remains 
unknown. To admit Ca2+ into the presynaptic terminal and promote Ca2+-dependent 
GABA release, NO may directly activate TRPC5 via S-nitrosylation, may act on an 
unidentified regulator of TRPC5 activity, or a combination of both. A western blot using 
immunoprecipitated TRPC5 after exposure to NO and probed for S-nitrosylation using 
“S-NO” antibodies, which recognize cysteine S-nitrosothiols, would reveal if native 
TRPC5 expressed in ACs becomes S-nitrosylated. To investigate if TRPC5 is being 
activated via S-nitrosylation, experiments using a mutated version of TRPC5 lacking the 
cysteine resides needed for S-nitrosylation could be overexpressed in these cells to see 
if the NO-dependent Ca2+ influx absent.  This would reveal if S-nitrosylation is the mode 
in which NO activates the TRPC5-mediated Ca2+ influx. 
Previously, it has been indirectly demonstrated that NO enhances Ca2+ 
dependent GABA release in the turtle inner retina due to NO-dependent reduced 
labeling of the preloaded GABA analog GVG (Yu and Eldred 2005). Additionally, 
another study found that NOS-stimulated NO production reduced ganglion cell ON and 
 84 
OFF light responses, with the OFF response being the most sensitive to NO (Wang et 
al. 2003). The reduced light responses were not due to intrinsic changes in ganglion cell 
membrane properties, suggesting that NO acts on a presynaptic site to enhance 
inhibition onto the ganglion cells. Because they are the only cells presynaptic to 
ganglion cells that provide inhibitory signals, ACs are likely the site in which NO acts. 
Combining the findings of these two studies with findings in my dissertation, NO may 
have reduced ganglion cell light responses (Wang et al. 2003) by increasing Ca2+-
dependent GABA release (Yu and Eldred 2005) through the NO-dependent TRPC5-
mediated Ca2+ influx in ACs.  
The physiological role of TRPC channels in the retina remains unclear. Future 
experiments using transgenic knockout models must be performed to validate this 
pathway by recording from cells in retinal slices that are postsynaptic to ACs (bipolar 
cells, ganglion cells or other ACs). The use of nNOS knockout mice to investigate this 
pathway would not produce reliable results. In a previous study, ganglion cell light 
responses in nNOS knockout mice required brighter light stimuli compared to normal 
mice, suggesting NO produced by nNOS is important for phototransduction in 
photoreceptors (Wang et al. 2007). Experiments using commercially available TRPC5 
knockout mice would confirm if ACs expressing TRPC5 are responsible for the NO-
dependent enhanced inhibition, without interrupting other NO-dependent mechanisms 
due to the loss of nNOS expression. If this nNOS-NO-TRPC5 pathway enhances 
GABAergic inhibition, ganglion cell light responses in TRPC5 knockout mice will be 
enhanced due to the loss of NO-dependent activation of TRPC5. 
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This enhanced NO-dependent GABAergic signaling at AC synapses may be 
highly localized. Activation of NMDA ionotropic glutamate receptors (NMDARs), coupled 
to a Ca2+-dependent NOS isoform (nNOS or eNOS), initiates NO production in the turtle 
retina (Blute et al. 2000). In the chicken retina, NMDAR activation increases NO 
production predominately in the INL and IPL (Tekmen-Clark and Gleason 2013). AC 
synaptic terminals can have multiple presynaptic sites, and in the turtle retina, nNOS 
can be present at one presynaptic site and absent at an adjacent presynaptic site within 
the same AC synaptic terminal (Cao and Eldred 2001; Eldred and Blute 2005). Light-
dependent and -independent activation of ON bipolar cells and OFF bipolar cells, 
respectively, provides glutamatergic input onto ACs. Activation of both pathways leads 
to increases NO production in the mouse retina (Blom et al. 2012) and salamander 
retina (Eldred and Blute 2005). Since the NO-dependent release of GABA is voltage-
independent, NO produced at one AC presynaptic site would eliminated the need for 
depolarization by diffusing to adjacent presynaptic sites and enhance NO-dependent 
GABA release from multiple presynaptic sites within the same AC synaptic terminal. 
This would enhance GABAergic inhibition of postsynaptic cell (s). Furthermore, if 
sufficient NO is produced and the postsynaptic cell receiving increased NO-dependent 
GABAergic input is another AC, NO would release intracellular Cl-, invert sign of the 
GABAergic input, and drive depolarization-dependent GABA release from the 
postsynaptic AC. This NO-dependent amplification of GABA release may be a 
mechanism needed to provide sufficient inhibition to properly process visual signals 
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